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CHAPTER I
INTRODUCTION
A.

Chemistry of Glomerular Basement Membrane and Group
A Type 12 Streptococcal Cell Membrane Antigens
The immunologic relatedness of the group A.type 12

streptococcal cell membrane (SCM) and human glomerular
basement membrane (GBM) has been documented by the use of
immunodiffusion analysis (3, 29), passive hemagglutination
(25, 29), and indirect fluorescent antibody tests (3, 4, 5).
The chemical basis for the observed immunochemical crossreactivity of the two membrane preparations remains to be
elucidated.
1.

~·

Present knowledge of the chemical structure of

human GBM consists mainly of amino acid and carbohydrate
analyses supplemented by theoretical considerations on a
possible macromolecular structure for GBM.

Table lA con-

tains several determinations by independent investigators
on the amino acid content of whole human GBM.

Table lB

contains percentages of the main carbohydrate constituents
of human GBM as determined by the same group of investigators.
1

2

Table 1.

Amino acid and carbohydrate composition of human
glomerular basement membrane.
A.

Hydroxylysine
Lysine
Histidine
Arginine
Hydroxyproline
Aspartic Acid
Threonine
Serine
Glutamic Acid
Proline
Glycine
Alanine
Half Cystine
Valine
Methionine
Isoleuc:i,ne
Leucine
Tyrosine
Phenylalanine
B.

Hexose
Hexosamine
Fucose
Sialic Acid

Amino acid composition (Residues/1,000
amino acid residues)
I ( 29)

II ( 2)

III (34)

17.0
22.0
11.0
37.0
79.0
70.0
37.0
55.0
95.0
70.0
244.0
70.0
9.0
36.0
15.0
26.0
62.0
17.0
29.0

24 .. 5
26.4
18.7
48.3
65.0
70.0
40.3
54.2
101.3
64.1
225.2
58.6
22.0
36.0
7.0
28.6
60.3
20.5
28.3

28.0
23.0
20.4
49.0
84.2
71.8
39.0
55.0
98.1
70.9
191.0
54.3
20.1
32.5
11.4
34.1
68.1
18.3
29.3

Carbohydrate Composition (mg carbohydrate/
100 mg protein)
I ( 29)

II ( 2)

III (34)

5.6
0.95
0.58
0.55

6.8
2.0
0.7
1.5

7.1
1.48
0.19
0.87

3

Markowitz and Lange (29) isolated and characterized
a soluble fraction (PGT-HUGL) of human GBM following trypsinization and extraction with trifluorotrichloroethane
(Genetron).

The PGT-HUGL had am. w. of approximately

20,000 as determined by its retention on Sephadex G-75,
sedimentation velocity and amino acid analysis.

The PGT-

HUGL contained a 2 to 3 fold increase in carbohydrate content
over the native human GBM, indicating that trypsin had cleaved
portions of the protein while areas of the GBM rich in carbohydrate remained intact (29).

The carbohydrate fraction of

PGT-HUGL was composed of galactosamine, glucosamine, galactose, glucose, mannose, and fucose.

It was speculated that

the oligosaccharide chain(s) was linked to the protein via
asparagine (23).
Material from the first fraction obtained by chromatography of PGT-HUGL on DEAE-cellulose (elution at PH 7.75
0.01 M phosphate buffer) was digested with papain (25).
The digest was subjected to high voltage electrophoresis and
chromatography to obtain a peptide map.

The main glyco-

peptides from several runs were pooled respectively and analysed for amino acid content.

The amino acid analyses of

whole GBM, trypsin resistant GBM, PGT-HUGL, and five frac-

4
tions from the peptide maps were compared.

Hydroxyproline

and hydroxylysine were present in all fractions.

The tryp-

sin resistant GBM contained a much higher proline content
than the other fractions, and contained no detectable hexose.
All the other fractions, with the exception of one fraction
from the peptide map of the papain digest, contained hexose.
A great deal of the structural work on GBM has been
done using bovine and canine sources of GBM.

A main

point

of disagreement between various investigators seems to be
whether or not a true collagen component is present in the
GBM.

Kefalides isolated a collagen component by limited

digestion of canine GBM with Pronase at
h (21).

4°c,

pH 7.2 for 10.0

This basement membrane "collagen" met the amino

acid criteria for collagen, that is, glycine accounted for
1/3 of the amino acid residues, while the sum of proline
and hydroxyproline accounted for 20-22% of the amino acid
residues.

However, the presence of the characteristic

triple helical structure consisting of three polypeptide
chains was not observed.

Kefalides attributed the lack of

helical structure to the abnormally high carbohydrate content of the basement membrane collagen as compared to tendon
collagen and stated:

"Excess neutral hexose prevents la-

teral end to end aggregation so that the desired structural

5

association with non-collagen glycoproteins is
( 2).

Kefalides also theorizes:

II

attaine~'

• • • It is possible that

collagen molecules exist at a low level of organization or
that the association with the non-collagen like proteins
interferes with the normal aggregative properties of the
collagen and/or interferes with the staining procedures
that bring about the periodic structure in electron microscopy" (14).· Other characteristics of the GBM collagen
isolated by Kefalides, as compared to tendon collagen, were
higher levels of hydroxylysine, hydroxyproline, and neutral
hexose ( 21).
Kefalides determined the hexose content of the
collagen to be 10% of the dry weight with glucose and
galactose coristituting all of the hexose and being in approximately equimolar amounts (21).

He found 95% of the

hexose to be in a disaccharide unit composed of glucose
and galactose while the other 5% consisted of the monosaccharide galactose (2).

Dische et al (9), using a hot TCA

extraction, was able to extract a "collagen component"
from human GBM and found carbohydrate associated with the
collagen extract consisting of essentially galactose and
glucose in a 4:3 ratio.

Spiro (36) digested bovine GBM

6

with collagenase for 72 h followed by treatment of the solubilized material with Pronase.

The soluble fraction was

then submitted to gel filtration over Sephadex G-25.
peaks were detected.

Two

The glycoproteins comprising the

second peak yielded ten fractions upon chromatography on
a Dowex 50 X-2 resin.

All ten fractions and the original

material from the second peak of Sephadex G-25 chromatography contained glucose, galactose, and hydroxylysine in
equimolar amounts.

The glucose and galactose formed a

disaccharide linked to hydroxylysine in a struc.ture of 2-0o©-glucopyranosyl-0-P-n-galactopyranosylhydroxylysine (36).
No mention was made of the isolation of a true collagen

.

like component and, therefore, the disaccharide moiety was
not attributed as being on a "collagen" subunit.
The void volume (first peak) recovered after filtration over the Sephadex G-25 column was then passed over
a Sephadex G-50 column.

The group of glycopeptides which

penetrated the G-50 column.contained sialic acid, galactose, mannose, fucose, and hexosamine, but no glucose or
hydroxyproline.

Spiro deduced that the heteropolysac-

charide is linked to asparagine in the bovine polypeptide
(36), an observation supported by Kefalides (14) for the
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heteropolysaccharide of canine GBM (see below).

The void

volume recovered after chromatography on Sephadex G-50 was
composed of several glycopeptides containing all of the
carbohydrates present in the native membrane (36).
Following prolonged digestion of canine GBM with
collagenase, Kefalides isolated insoluble and soluble fractions (2).

Further treatment of the insoluble fraction

with reduction and alkylation in 8.0 M urea resulted in
the isolation of large m. w. glycoprotein fraction in the
void volume obtained after chromatography on Sephadex
G-200.

The glycoprotein fraction contained no hydroxy-

proline or hydroxylysine, but did contain a heteropolysaccharide composed of galactose, mannose, fucose, hexosamine, and sialic acid.
The soluble fraction obtained after collagenase
digestion of canine GBM contained a.small m. w. glycoprotein which penetrated the gel of Sephadex G-200.

It had

a m. w. of 30,000 dalt. and contained galactose, mannose,
fucose, sialic acids, and twice as much hexosamine as the
large m. w. glycoprotein (14).
Kefalides proposed that the collagen component is
linked to the small m. w. glycoprotein via disulfide bridges
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and that the complex was associated with the large m. w.
glycoprotein via hydrogen and disulfide bonds.

He based

his proposal on (i) data concerning the solubility of GBM
after treatment with 8.0 M urea or reduction and alkylation using mercaptoethanol and iodoacetamide, and (ii) the
effect on GBM, as observed in electron microscopy, of reduction and alkylation using mercaptoethanol and iodoacetamide (2, 14).
2.

SCM.

Extensive work on the chemistry and structure

of the group A, type 12 SCM has not been reported.

Freimer

deduced that 85% of the SCM was composed of a lipoprotein
complex (11).

The membrane was found to contain 25% lipid,

71% protein, and 2% carbohydrate, which he stated was
"mainly glucose".

Freimer also reported that the group

A type 12 SCM contained 3.0% RNA, 1.0% phosphorous, 11.4%
nitrogen, 19.1% lipid, and 1.9% glucose.

Lange reported

an amino acid analysis of the whole type 12 SCM, which
is given in-Table 2 (25).
Markowitz and Lange obtained a soluble fraction
of group A, type 12 SCM(PGT-CM) following trypsinization
and extraction with Genetron (29).

PGT-CM was found to be

•
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Table 2.

Composition of the group A, type 12 streptococcal cell membrane in mg/100 mg amino acids.
Lysine
Histidine
Arginine
Aspartic Acid
Threonine
Serine
Glutamic Acid
Praline
Cysteic Acid
Glycine
Alanine
Valine
Methionine
Isoleucine
Leucine
Tyrosine
Phenylalanine
Alloisoleucine

9.1
1.8

4.4
9.7
5.4
5.7
12.6
3.1
0.1

7.1
15.7
6.4
0.6

5.4
7.0

2.4
3.3

+*

* "+" indicated presence of the amino acid in too low of
a concentration to be calculated
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80% protein, 7% carbohydrate, 3.7% phosphorous, and .2%
hexosamine.

PGT-CM contained no detectable sialic acid.

The carbohydrate fraction of PGT-CM was composed of rhamnose, ribose, glucose, galactose, glucosamine and galactosamine.

The molecular weight of PGT-CM was approximated

to be 8,500 dalt. by utilizing ultracentrifugal data,
behavior of PGT-CM in Sephadex G-75 chromatography, and
amino acid analysis (29).
If the chemical basis for the immunologic relatedness of human GBM and group A, type 12 SCM is to be elucidated, a great deal of biochemical analysis is still needed
on the SCM and GBM.

The bulk of the information in this

short review on an actual structure for GBM has been concerned with canine and bovine GBM; similar results have not
been duplicated for human GBM.

Moreover, very little is

known about the primary chemical structure of the type 12
SCM.
However, elucidation of the chemical structures of
the GBM and type 12 SCM is not the ultimate goal of this
project.

Here interest is directed as to why anti-SCM

antisera react with GBM preparations in immunochemical
tests and, conversely, why anti-GBM antisera react with

11

SCM.preparations in imrnunochemical tests, with the main
goal being to see if affinity chromatography will provide
a useful tool in this endeavor.
B.

Affinity Chromatography
Affinity chromatography is a method of purifying

a macromolecule on the basis of its biological or biochemical function.

One form of the method consists of covalently

binding a biologically active protein to an insoluble matrix
and passing over the affinity matrix a solution containing
the macromolecule with the biological property of binding
selectively and reversibly to the ligand attached to the
insoluble matrix.

The macromolecule is then eluted after

all non-specific molecules have been washed out of the matrix.
For enxyrne purification, the ligand may be a competitive
inhibitor, coenzyrne, or substrate of the enzyme.

Hormones

can be purified in columns with their receptor proteins as
ligands; and irnrnunoadsorbent columns contain either antibody or· antigen as ligand, depending on whether it is desired
to purify antibody or to purify antigen.
A good insoluble matrix would be composed of a
polymer which interacts weakly with proteins in general to
prevent non-specific adsorption, should possess chemical

12
groups that can be activated or modified (in order to bind
ligand) under conditions that would not alter significantly
the structure of the matrix, should be stable to the conditions involved in coupling the ligand and eluting the
purified molecule, and finally should form a loose porous
network which allows entry and exit of large macromolecules
(31).

Utilizing the above criteria, Sepharose (Pharmacia

Fine Chemicals, Uppsala, Sweden) is an ideal matrix.

Other

commonly used insoluble polymers such as cellulose, starch,
destran, and polyacrylamide usually have undesirable affinities for the substance to be fractionated, which is probably due to carboxylic groups which lead to absorption via
electrostatic attraction (31).
Sepharose 4B is an insoluble matrix composed of
spherical agarose gel beads with an exclusion limit of
20 X 10

6

dalt. for proteins.

Agarose is a linear polysac-

charide consisting of alternating residues of D-galactose
and 3, 6 anhydro L-galactose units.

The cyanogen bromide

method (1) for the activation of Sepharose causes formation of cyclic and acyclic imidocarbonates by virtue of the
reaction of CNBr with the hydroxyl groups of the Sepharose
polymer.

During the coupling of ligand to the CNBr acti-

13

vated Sepharose the ligand reacts through amino groups with
the imidocarbonate to form mainly isourea derivatives (38).
The purpose of an immunoadsorbent is to provide a
quick and easy method for isolating specific antibody free
of other serum proteins and of the antigen.

The method

has the advantage of isolating non-precipitating antibodies
and antibodies in too low a concentration to be detected by
classical precipitin techniques.

Also, an immunoadsorbent

may be used in the opposite sense; that is antibody specific
for a certain antigen may be used as ligand on an immunoadsorbent for the isolation of antigen.
To ascertain if the Sepharose immunoadsorbents will
provide a tool in determining the structural basis for the
immunologic relatedness between GBM and SCM, two parameters
of the Sepharose immunoadsorbents must be investigated.
First, the Sepharose immunoadsorbents must be capabie of
isolating cross.-reactive antibody from heterologous sera
for the antigen bound to the immunoadsorbent.

The capability

of the Sepharose immunoadsorbent to isolate cross-reactive
antibody could be investigated by binding antigens of known
chemical structure to Sepharose 4B, and passing samples of
both homologous and heterologous sera over the immunoad-

...
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sorbents.

A comparison of the amount of antibody eluted

and the antigenic specificity of eluted antibody from the
two serum samples would give a good indication of the
ability of the Sepharose immunoadsorbents to isolate cross
·reactive antibody.
Secondly, the effects of enzymatic digestion of
antigen on the binding properties of the antigen to Sepharose and subsequent binding of antibody to the Sepharose
bound ligand must be compared to the same properties of _the
antigen in its native form.

To study this problem, an

antigen of known chemical structure could be enzymatically
digested (e.g.-trypsin, collagenase, sialidase), and bound
to Sepharose.

The binding properties of the enzyme treated

antigen-immunoadsorbent would then be compared to the binding
properties of a native antigen-immunoadsorbent.
Knowledge of the properties of Sepharose concerning
cross reactive antibody (and, therefore, cross reacting
antigen) and enzymatically digested antigens could then be
applied to GBM and SCM.

Theoretically, various antigenic

preparations of SCM and GBM may be used as ligands.

The

preparations would be prepared using various enzymes (trypsin, pronase, collagenase, fucosidase).

By passing various
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antisera prepared in rabbits against different SCM and GBM'
antigenic preparations, antibody would be isolated specific
for antigens on the SCM and GBM ligands.

Also, anti-SCM

sera could be passed over GBM-Sepharose irrununoadsorbents
(or anti-GBM sera over SCM-Sepharose irrununoadsorbents) to
isolate cross reactive antibody.

Ultimately, the specific

antibody would be bound to Sepharose, and the immunoadsorbent used to isolate antigen.

Antigen isolated from various

antibody-immunoadsorbents would then be isolated and compared for chemical and structural relatedness.
The problem arises that an antisera to a given
protein or glycoprotein antigen consists of a mixed population of antibodies with specificities for different
antigenic determinants.

Therefore, ideally the original

antisera would be prepared against chemically well defined
antigens, and the chemical compositions of the antigens
used as ligand would also be well defined.

A high degree

of chemical characterization of the GBM and SCM antigenic
preparations has not been attained yet.
A goal of this research project will be to analyse
the ability of Sepharose immunoadsorbent columns to quantitate the amount of antibody in a serum specific for the
ligand on a particular Sepharose immunoadsorbent.

...

The
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method would consist of passing a given volume of antiserum
over a Sepharose immunoadsorbent, and then determining the
concentration of specific antibody eluted off the immunoadsorbent.
of the

The concentration would be calculated on the basis

o.

D. of the eluted fraction.

Gill and Bernard,

utilizing a BSA-bromoacetyl cellulose immunoadsorbent, used
a spectrophotometric method to determine the concentration
of anti-BSA antibody adsorbed from sera (13).

Also, Wofsy

and Burr, utilizing a para-aminophenyl-~-lactoside-Sepharose
immunoadsorbent, used a spectrophotometric method to determine the concentration of anti-hapten antibody adsorbed
from ascites fluid obtained from mice immunized with paraazophenyl-P-lact~s ide-keyhole limpet hemocyanin (46).

Other immunoadsorbents have been used in the past
to determine specific antibody concentration in a given
solution (6, 12, 18, 28, 30, 41, 42).

However, the con-

centration of the purified antibody was usually determined
utilizing classical precipitin techniques, which are (i)
incapable of detecting non-precipitating antibody and (ii)
destructive of the antibody being quantitated.
Two requirements must be satisfied before the concentration of antibody in the eluted fraction is used to
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determine the amount of specific antibody ih a given
serum sample.

First, saturation of column antigen sites

must be avoided, a condition met only if the volume of
the serum sample passed over the immunoadsorbent does not
contain specific antibody in excess of available immunoadsorbent antigen sites.

Therefore, specific antibody

activ'ity should not be detectable in the effluent (composed
of non-specific antibody and other serum proteins) fraction.
Secondly, if the

o.

D. of the eluted fraction is to be used

in the calculation of the antibody concentration, the eluted
fraction must be free of serum proteins other than antibody.
Initially, precipitin ring tests consisting of samples of the effluent fraction vs. a solution of the particular antigen involved will be used to detect specific
antibody activity in the effluent fraction.

The more sen-

sitive method of passive hemagglutination, utilizing antigen
coated pyruvic aldehyde stabilized RBC (19), will also be
used to detect specific antibody activity in the effluent
fraction.
There have been conflicting reports, both confirming (16, 47) and refuting (20) contamination with
serum proteins of eluted fractions obtained from immunoad-
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sorbents.

Therefore, immunoelectrophoresis will be used

to determine if the antibody fraction eluted from the
Sepharose imrnunoadsorbent is contaminated with other serum
proteins.
If the Sepharose irnmunoadsorbents provide a viable
method for quantitating the amount of antibody in a serum
specific for the ligand on a particular Sepharose irnmunoadsorbent, an explanation may be given for the titers in
indirect fluorescent antibody tests obtained by Blue (3)
of two anti-SCM and two and two anti-GBM sera.

The SCM

antisera were linearly diluted in one fold fashion and the
GBM antisera diluted linearly in sixteen fold fashion.
Each dilution was tested in indirect fluorescent antibody
tests on untreated and carbohydrase (32) treated human
kidney sections to obtain titers, the endpoint being the
highest dilution showing a

± GBM

fluorescence.

If the

concentrations of the antibody specific for GBM in the sera
were determined, the question may be answered as to whether
the difference in fluorescence on human kidney sections of
antisera prepared against SCM and GBM antigen preparations
is due to a difference in the size of a heterologous population of antibody specific for various antigenic determinants
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on the GBM, or due to antibody of a relatively restricted
heterogeneity with high affinity for a small number of
antigenic sites.
Recovery of activity of the isolated antibody from
irrnnunoadsorbent columns will be investigated.

A knowledge

of the concentration of specific antibody in an antiserum
would be useless unless knowledge of the loss of antibody
activity due to the physical manipulation of the sample
(i.e. elution, concentration, and reconstitution) is obtained.

To determine recovery of activity, the activity

of the original antiserum in a given irrnnunological test
must be compared to the activity of the eluted antibody
fraction recovered from chromatography of the antiserum on
an irrnnunoadsorbent.

The method for measuring the activity

should be easy to perform, rapid, and reproducible.

Methods

which were considered included a radioirrnnunoassay, microcomplement fixation, and passive hemagglutination.

Problems

inherent to the method of the radioirrnnunoassay are the
necessity for the construction of standard curves whenever
an assay is run or new labelled protein preparations are
used.

Also, the methodology involved with the use of

radioisotopes including handling, storage life of isotop-

...

20

ically labelled protein, and the detection of label lessened
the attractiveness of the method.

For best results in the

micro-complement fixation test optimum hemolysis of the
sheep RBC must be determined, which necessitates deter-

.

mination of optimum concentrations of sensitizing antibody
for the sheep RBC, complement, and of the test antigen,
procedures which would in all probability have to be repeated for each new combination of an antiserum and antigen
used.

Passive hemagglutination using pyruvic aldehyde

stabilized RBC (19) seemed, therefore, to be the best
method.

The same ligand which is attached to a Sepharose

immunoadsorbent may be attached to the activated RBC; the
ligand bound cells can be stored for prolonged periods,
and the original antiserum can be titrated the same day

~s

the unknown sample thus providing a rapid and accurate means
for comparison of activity.
It is therefore proposed to investigate the ability
of Sepharose 4B immunoadsorbents to isolate antibody both
specific and cross reactive for the ligand attached to the
immunoadsorbent, and to determine whether the immunoadsorbents are capable of providing a rapid method for quantitating in antisera antibody specific for the ligand attached
to the immunoadsorbent column.

Sepharose 4B immunoadsorbents
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will be constructed using as antigens BSA, HSA, BGG, RGG,
HGG, protease, sialidase treated protease, and trypsin
solubilized preparations of GBM and SCM.

In addition,

activity of the isolated specific antibody will be determined in passive hemagglutination assays.

CHAPTER II
MATERIALS AND METHODS
A.

Source of SCM
Group A, type 12 SCM were isolated previously using

the method of Markowitz and Lange (29).

The insoluble

membrane from treatment of separate samples of SCM with
either sodium deoxycholate (Difeo, Detroit, MI), 2-chloroethanol (Eastman, Rochester, NY), or Triton-X-100 (Eastman,
Rochester, NY), were pooled and used as a source of SCM.
B.

Source of Kidneys
Human autopsy kidneys were obtained from the

Department of Pathology, Hines Veterans Hospital, Hines,
Illinois.

All kidneys were adjudged to be free of gross

pathology and were from non-renal involved necropsies.
C.

Isolation of GBM
Glomeruli were isolated by the method of Krakower

and Greenspan (22).

The cortices were separated from the

medulla using a scalpel, and innnediately placed in cold
phosphate buffered saline (PBS).

The washed cortices were

then pushed through steel wire mesh screening (100 mesh,
F. P. Smith Cloth Co., Franklin Park, IL).with a spatula
22
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into a container kept on ice.

Cold PBS was added to resus-

pend the sediment, which was then centrifuged at 2,000 rev/
min for 3 to 4 min.

The supernatant was decanted off and

the sediment, which contained the glomeruli, was resuspended
in PBS.

The glomeruli were then washed and purified by

allowing then to settle by gravity 3 to 4 times while
washing with cold PBS.

The purity of the glomerular pre-

paration was determined by the absence of epithelial cells
under visualization with light microscopy.

The suspensions

were further washed until free of tubules and debris.

Iso-

lated glomeruli were then washed with deionized water,
pelleted by centrifugation and stored frozen until used
for the isolation of GBM.
GBM was isolated by the method of Krakower and
Greenspon (22).

Glomerular pellets were resuspended in

PBS to a final concentration of 10% w/v.

They were then

sonicated at maximum intensity with a Branson sonifier,
model S-75 (Branson Instruments Inc., Stamford, Connecticut)
for 6 min. and checked with light microscopy to make certain that all glomeruli were disrupted.

The sonicated

material was centrifuged at 1,800 rev/min for 10 min.
The resultant pellet contained the glomerular basement
membrane.

The GBM pellets were then washed twice in PBS
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and once in deionized water, and centrifuged at 1,800 rev/
min for 10 min after resuspending the pellets.

After being

checked by microscopy for purity (i.e. absence of Bowman's
capsule), isolated GBM was lyophilized, weighed, and stored
for further use.
D.

Enzymatic Digestion of GBM, SCM, and Protease
GBM and SCM were digested using bovine pancreas

trypsin (Sigma Chemical Corp., St. Louis, MO).

A weight

ratio of 100/1 (mg membrane preparation/mg trypsin) was
used for the digestion.

The membrane preparation and tryp-

sin were mixed together in 0.07 M phosphate buffer, pH 8.1
to a volume corresponding to 1.0 ml of buffer/10 mg of
membrane to be digested.
.

The solution was stirred inter-

0

mittently for 6 h at 37 C, followed by stirring overnight
at 4°C with a magnetic stirring bar.

The solution was then

centrifuged at 20,000 rev/min for 30 min.

The supernatant

was carefully decanted off, and dialyzed in 3,500 dalt.
exclusion Spectrapor (Spectrum Medical Industries, Inc.,
Terminal Annex, Los Angeles, CA) membrane tubing against
250 ml of deionized water for two days at 4°c, the deionized ·
water being changed each day.

The contents of the membrane

tubing were transferred to 8,000 dalt. exclusion Spectrapor

..
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membrane tubing and again dialyzed for two days at 4°c
against 250 ml of deionized water, with daily water changes.
Finally, the contents of the membrane tubing were poured
into a 10,000 dalt. exclusion dialysis tubing (Union Carbide, Chicago, IL) and dialyzed against deionized water

. h t at 4°C.
overnig

The contents of the dialysis bag and

the five 250 ml volumes were each lyophilized, weighed
and stored.
The pellet of insoluble GBM from the trypsin digest
was washed in deionized water, resuspended in deionized
water and lyophilized.

The recovered trypsin resistant

protein was then weighed and retrypsinized using the same
procedure as above.

The resultant trypsin resistant GBM

was then digested with carbohydrase (32) using the same
procedure used for the trypsin digestion with the following
modifications.

The carbohydrase-GBM mixture was placed in

a piece of 10,000 dalt. exclusion dialysis tubing.

The

tubing was then placed in a graduate cylinder containing
10.0 ml of PBS.

After 6 h of digestion, the contents of

the bag were poured into a 40.0 ml beaker, and trypsin was
added directly to the mixture.

The 10.0 ml of PBS from

the graduate cylinder was tested for the presence of carbo-

•
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hydrate using the Molisch (15) test.

The same dialysis

and recovery methods used for the trypsin digest were used
in handling of the carbohydrase-trypsin digest (tryp-carbsol-GBM).
Protease, isolated by the method of Lange (24),
was treated with neuraminidase (Sigma Chemical Corp., St.
Louis, MO) to remove sialic acid.

An amount of protease

was dissolved in 0.1 M acetate buffer, pH 5.0, to yield a
4.0 mg/ml solution.

Substrate, acetate buffer, and enzyme

were mixed in a 2/2/1 ratio and incubated for 1 h at 37°c.
Percent release of sialic acid was determined by the direct
Ehrlich method (45) by measuring the sialic acid content of
the protease before and after digestion.
E.

DEAE Cellulose Chromatography
Fractionation of trypsin solubilized GBM (greater

than 10,000 dalt.) was performed on a 1 X 30 cm glass
column containing a 10 ml bed volume of DEAE cellulose
(Eastman, Rochester, NY).

The DEAE cellulose was first

equilibrated by passing 20 volumes (200 ml) of 0.005 M
sodium phosphate buffer, pH 7.8 over the column; 100 mg
of the sample was added in 5.0 ml of 0.005 M sodium phosphate buffer pH 7.8.
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Elution was carried out sequentially using the
following sodium phosphate buffers of increasing molarities
and decreasing pH; 0.005 M, pH 7.8; 0.01 M, pH 6.1; 0.02 M,
pH 7.0; 0.04 M, pH 6.0; 0.06 M, pH 5.0; 0.1 M, pH 5.0; and
0.3 M, pH 4.0.

All fractions were collected in 5.0 ml test

tube amounts with a Fractomat (Buchler Company, Fort Lee,
NJ) automatic fraction collector.

Fractions were scanned

at 280 nm and recorded on a Gilson tricorder.

Appropriate
0

tubes were pooled, dialyzed against deionized water at 4 C
for three days, lyophilized and stored.
F.

Amino Acid Analyses
Quantitative amino acid analyses of GBM prepara-

tions, SCM, GBM-Sepharose, BGG-Sepharose, and RGG-Sepharose
were performed with a Beckman model 120C amino acid analyzer
as previously described (23, 25, 29).

Approximately 1.0 mg

amounts of samples, or volumes of packed Sepharose theoretically containing 1.0 mg amounts of protein, were hydrolyzed in evacuated test tubes containing 1.0 ml of 5.7 M
0

constant boiling HCl, at 110 C for 22 h.

After hydrolysis,

the tubes were opened and the contents dried over sodium
hydroxide in a vacuum dessicator.

Samples were solubilized

with 2.2 ml of 0.2 N citrate buffer, pH 2.2 and duplicate
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•

1.0 ml samples were placed on the short and long column,
respectively.
G.

Antis era
All of the SCM and GBM antisera utilized in this

study were previously prepared in rabbits and tested for
antigenic specificity (26, 27).

Complete Freund's adjuvant

was compo'sed of Marcol-52 (Humble Oil and Refining Cos.)
containing lyophilized Mycobacterium tuberculosis strain
H37Ra cells (2.5-5.0 mg/20 ml complete Freund's adjuvant),
Falba (Pfaltz and Bauer, Inc., Flushing, NY), and PBS
containing the particular antigen) in a ratio of 2:1:1.
Initially, each rabbit received 2.0 mg of antigen in
complete Freund 1 s adjuvant distributed in foot pads and
subcutaneously in the neck.

Fourteen days later, each

animal was injected intramuscularly with 1.0 mg of antigen
in incomplete Freund's adjuvant.

One week after the last

inoculation, the animals were exsanguinated.
Twenty two antisera were prepared in 22 separate
rabbits against seven chemically defined preparations of
group A, type 12 SCM.

The chemical treatments yielding

soluble fractions of SCM included sodium lauryl sulfate
(SLS-SCM), cyanogen bromide (CNBr-SCM), pepsin (Pep-SCM),
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pepsin and CNBr (Pep-CNBr-SCM), and sodium lauryl sulphate
and cyanogen bromide (SLS-CNBr-SCM) (27).

Also, antisera

were prepared against material from the second peak of
DEAE cellulose chromatography of sodium lauryl sulphate
solubilized SCM (SLS-SCM II), the insoluble SCM precipitate
following pepsin digestion of SCM (Pep-Insol-SCM), and
whole insoluble SCM(SCM).
Six glomerular preparations are represented by
ten antisera.

The antisera were prepared against GBM

solubilized by treatment with sodium lauryl sulfate and
cyanogen bromide (SLS-CNBr-GBM); material from the second
and third peaks of DEAE cellulose chromatography of glomeruli (GLOM) solubilized by treatment with Genetron and
trypsin (PGT-HuGlom II and PGT-HuGlom III); insoluble,
trypsin resistant GBM (Tryp-Res-GBM); whole glomeruli
(HuGlom); and whole GBM (HuGBM).
Other antisera included equine anti-whole rabbit
serum (anti-WRS, from Kallestad Laboratories, Minneapolis,
MN), goat anti-rabbit gamma globulins (anti-RGG, supplied
by Dr. Lange); sheep anti-human serum albumin (anti-HSA,
supplied by Dr. Lange) and anti-human light chain of IgG
(anti-HLC, supplied by Dr. Lange); and rabbit anti-bovine

F'

r
<:;

f.
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serum albumin (anti-BSA, supplied by Dr. Lange), anti-human
ganuna globulin (anti-HGG, supplied by Dr. Lange), antibovine gamma globulin (anti-BGG, supplied by Dr. Lange),
anti-goat gamma globulin (anti-GGG, from Kallestad Laboratories, Minneapolis, MN), and anti-human urinaryo< -acid
1
glycoprotein

(an~i-proteose,

supplied by Dr. Lange).

Normal rabbit serum (NRS) and normal sheep serum (NSS)
were each a pool of preimmunization bleedings supplied
by Dr. Lange.
H.

Affinity Columns
The method of Cuatrecasas (7) was used for the

activation of Sepharose 4B (Pharmacia Fine Chemicals Inc.,
Piscataway, NJ) with CNBr (Eastman Kodak, Rochester, NY).
A slurry of Sepharose-4B was allowed to settle, the water
decanted off the surface of the packed gel, and the gel was
resuspended in 10 volumes of deionized water.

The process

was repeated several times in order to remove the "fines"
and also the sodium azide preservative.

After the final

wash, the volume of the packed gel was estimated and an
equal volume of deionized water was added.

For every ml

of settled Sepharose-4B, 100 mg of CNBr was used in the
activation step.

The appropriate amount of CNBr was dis-
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solved in a volume of deionized water equal to that of the
Sepharose slurry.

The pH of the Sepharose slurry was ad-

justed to 11 •. 0 by the addition of 4.0 M NaOH, and the CNBr
solution was added.

While stirring with a glass rod, the

pH was monitored and held at 11.0 by the addition of 4.0 M
NaOH dropwise with a Pasteur pipette.

Once the pH remained

at 11.0 without further addition of base (approximately 1015 min at room temperature) the activation step was complete.
The activated gel was washed with 20 volumes of cold
0.1 M bicarbonate buffer, pH 8.65 on a Buchner funnel, and
resuspended in 0.05 M phosphate buffer pH 7.5 up to a volume
equal to that of the original Sepharose slurry.

The ligand

(S.O mg/1.0 ml packed Sepharose) was quickly added in an
amount of 0.05 M phosphate buffer, pH 7.5 corresponding to
5-15% of the final volume of the Sepharose-ligand mixture.
The test tube containing the mixture was then placed on a
rotating circular test tube rack for end over end mixing
0

at 4 C for 24 h.

The coupled gel was washed with 0.05 M

phosphate buffer pH 7.5 on a fine sintered glass filter.
The wash was dialyzed against deionized water for 3 d at

4°c with daily water changes and lyophilized to obtain the
dry weight of the unbound ligand, a value which was then
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used for the determination of the amount of ligand which
had attached to the gel.

The gel was washed four to five

times with alternate 50.0 ml volumes of 0.1

~

borate buffer,

pH 8.5 and 0.1 M sodium acetate buffer, pH 4.0.
Approximately 5.0 ml of the completed gel was
poured into a glass column (1 X 15 cm) over a 1.0 cm glass
wool plug, with a filter paper disc separating the gel from
the glass wool.

Several volumes of 0.05 M sodium phosphate

buffer, pH 7.5 were passed over the column prior to the
addition of the sample of antiserum until a baseline was
established on the Gilson recorder.

After the entire volume

of antiserum had entered the gel, phosphate buffer was continuously added to the column until it became apparent from
the recorder that the effluent had passed through the column.
Elution of the bound protein was carried out with the fraction collector collecting approximately 6.0 ml/test tube
volumes.

To check for saturation with antibody of the avail-

able antigen sites on the column, each tube comprising the
effluent fraction was observed for precipitation with a 3.0
mg/ml sample of antigen in precipitin ring tests.

Tubes

comprising the effluent and eluted fractions were pooled
separately.

The O.D. of the eluted fraction was in some
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cases determined on a Hitachi Perkin Elmer Model 139 UV-VIS
spectrophotometer (Tokyo, Japan) at 280 nm, in order to
gain an initial estimate of the antibody concentration.
The fractions were then dialyzed against deionized water
0

for 3 d at 4 C and lyophilized.
The lyophilized samples were reconstituted in a
volume of borate buffered saline (BBS), pH 8.0, corresponding to the original volume of the serum sample.

o.

The

D. of the eluted fraction was determined for an estima-

tion of its antibody content.
Antigens coupled to Sepharose included:

BSA

(Sigma Chemical Co., St. Louis, MO); BGG and HGG (Pentex
Inc., Kankakee, IL); HSA and RGG (supplied by Dr. Lange):
proteose, neuraminidase treated proteose, trypsin solubilized GBM (greater than 10,000 dalt.), and trypsin solubilized SCM (greater than 10,000 dalt.).
I.

Irrnnunoelectrophoresis
Immunoelectrophoresis of selected eluted antibody

fractions was performed with 1.5% Ionagar (Colab, Chicago
Heights, IL) gels on glass slides with a Gelman (Gelman
Instrument Co., Ann Arbor, MI) immunoelectrophoresis apparatus.

Electrophoresis of the antigens (1.0 mg/ml solutions
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of eluted antibody fractions in BBS) was run for 100 min
at 30 mA and 100 volts in 0.10 M barbital buffer, pH 8.6.
The undiluted antisera were added and immunodiffusion
carried out for 38 h in a moist chamber ut room temperature.
The slides were then washed 2 d in saline followed by washing for 2 d in deionized water.
After drying, the gels were stained with Napthalene
Black 12B (Allied Chemical and Dye Corporation, New York,
NY) in methanol, glacial acetic acid, and water (5:2:5),
and then destained in a solution -0f methanol, glacial acetic
acid, and water (7:1:2).

J.

Hemagglutination Assays
Type

o,

Rh negative human erythrocytes and rabbit

erythrocytes were stabilized and tanned by the method of
Hirata (19).

The 1.0% RBC solution was distributed in 3.0

ml volumes into 5.0 ml glass vials, frozen in a dry ice and
0

acetone bath, and stored at 0 C.

After a vial of cells

was thawed, antigens were adsorbed to the surface of the
RBC by the addition of 3.0 ml of a 0.1% solution of the
test antigen (O.l M acetate buffer, pH 3.5) to 27.0 ml of
stabilized erythrocytes (in the same acetate buffer).
final concentration of the RBC was 1.0%.

The

The mixture was
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incubated at 37°C, with gentle stirring, for 1 h.

The cells

were then washed in.10.0 mlof0.11 M sodium phosphate buffer,
pH 7.2 five times by centrifuging at 1,000 rev/min for 15
min between each wash.

After the final ·wash, the cells were

resuspended in phosphate buffer to a volume yielding a 1.0%
solution, and stored at 4°C.

For determining titers, 1.0

ml of the 1.0% solution was diluted in phosphate buffer to
a volume yielding a 0.25% solution.
Antigens coupled to cells include BSA, HSA, RGG,
BGG, HGG, protease, neuraminidase treated protease, trypsol-SCM (greater than 10,000 dalt.), tryp-sol-GBM (greater
than 10,000 dalt.), tryp-carb-sol-GBM, DEAE Fraction I of
tryp-sol-GBM, and tryp-sol-GBM (3,500-8,000 dalt.).
The titer of each antiserum and the titers of the
reconstituted effluent and eluted fractions from passage
of the antiserum over an antigen-Sepharose column were
determined simultaneously (in duplicate) using Cooke Engineering Co. (Alexandria, VI) Microtiter equipment.

In addi-

tion, a volume of each eluted fraction was diluted with an
equal volume of NRS and titers of each antiserum and matched
effluent and NRS diluted eluted fractions were determined
in

duplicate~

Titers are reported as the reciprocal of the

...
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highest dilution showing visible hemagglutination; and an
approximation of the log
K.

2

of the titer was also recorded.

Production of Hemorrhagic Necrosis in Guinea
Pigs Using Anti-SCM and Anti-GBM Antisera
A single guinea pig was bled from the heart in

order to obtain erythrocytes for use in slide agglutination
tests and absorption of antisera.

The guinea pig blood was

centrifuged at 2,000 rev/min for 10 min, washed with PBS
and centrifuged again at 2,000 rev/min for 20 min.

The

pellet, representing approximately 2.0 ml of guinea pig
RBC, was resuspended to a final volume of 10 ml in PBS.
Slide agglutination tests were performed by placing
a drop of the guinea pig RBC suspension and a drop of an
antiserum on a slide (all antisera were first inactivated
at 60°C for 3 min).

The two drops were then mixed with a

wooden applicator stick.

All

"+"

agglutinating antisera

were then absorbed with guinea pig RBC by adding two volumes
of packed cells to each volume of antisera.

The absorbed

antisera were again checked with the slide agglutination
test, and if still positive, were reabsorbed with guinea
pig RBC.
The backs of guinea pigs were shaved and 0.1 ml
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of antiserum was injected subcutaneously into one of five
sites on the back of each guinea pig (four different antisera/guinea pig, with NRS in the middle of the back of
each animal) followed approximately one min later by the
injection of 0.1 ml of epinephrine (1.0 mg/ml) adjacent
to each site.

Responses were observed after 24, 48, 72,

96, and 120 h.

All necrotic lesions were measured, by

measuring the length and width of each lesion as uniformly
as possible, and also by taking Kodak Ektachrome-X(ASA 64)
color slides using a Kodak Instamatic camera.

Responses

were graded as+ (definite redness), 2+ (lesion 10 X 10 nun),
3+ (lesion 15 X 15 nun), and 4+ (lesion greater than 20 X
20 MM).
L.

Fluorescent Antibody Tests
Indirect fluorescent antibody tests (43) were done

on human kidney cortex sections using effluent and eluted
fractions from affinity chromatography of a rabbit antiPGT HuGlom II serum.

A 5.0 ml sample of the serum was

passed through a column of trypsin solubilized GBM
dalt.-Sepharose.

10,000

After elution, the effluent fraction was

passed through the column again.

After dialysis and lyo-

philization, the effluent fraction was reconstituted to its
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original volume, of 5.0 ml with BBS.

One ml of this pre-

paration was then used to reconstitute the pooled eluted
fractions.
Kidney cortex sections were sliced 2 microns (u)
thick.

Two sections were evaluated/slide.

On each slide

a sample of antiserum, effluent or eluted antibody fraction,
NRS, or saline were overlayed on the sections and incubated
at room temperature for 45 min.

The slides were then washed

3 times in PBS, for 10 min/wash.

The slides were dried by

pressing between paper towels and then overlayed with a
1:40 dilution of fluorescein conjugated sheep anti-rabbit
garrnna globulin which had been absorbed with charcoal powder
(previously prepared).

The slides were incubated for 30

min at room temperature in a moist chamber and then washed
and dried as described above.

Sections were mounted with

cover slips in 90% glycerol, 10% PBS and observed with a
Leitz Wetzlar (E. Leitz, Inc., Rockleigh, NJ) fluorescence
microscope for glomerular staining.

All fluorescent anti-

body slides were read by 3 independent viewers to confirm
gradations of reactivities.

...

CHAPTER III
RESULTS
A.

Isolation of GBM
From sixteen human autopsy kidneys, approximately

39.3 gm (wet weight) of whole glomeruli were isolated,
which yielded 1.2 gm (dry weight) of GBM.
B.

Enzyme Digestions
Initially, 500 mg of human GBM was

d~gested

with

5.4 of trypsin in 50 ml of 0.07 M phosphate buffer, pH 8.1.
From this, 179.0 mg of insoluble material was recovered,
while the soluble fraction contained 156.4 mg of material,
over 10,000 dalt., 5.0 mg of 8,000-10,000 dalt. material,
and 42.0 mg of material with 3,500-8,000 dalt.

Total re-

covery was 382.4 mg, representing a 76.5% recovery of the
starting material.
The 179.0 mg of trypsin resistant GBM was retrypsinized, by 1.79 mg of trypsin in a volume of 18.0 ml of
0.07 M phosphate buffer, pH 8.1.
contained 137.5 mg of

ma~erial;

The insoluble fraction
and the soluble fraction

contained 20.0 mg of material over 10,000 dalt., 1.1 mg
of material 8,000-10,000 dalt., and a trace of material
39

r,.
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of 3,500-8,000 dalt.

Total recovery was 158.6 mg, represen-

ting 88.6% recovery of the starting material.
The 117.0 mg sample of resultant trypsin resistant
GBM was digested with 1.0 mg of carbohydrase in 10.0 of
PBS.

The Molisch test, performed as described in Materials

and Methods, was negative.

After 6 h, the dialysis bag was

opened, and 1.0 mg of trypsin was added to the digestion.
Following the additive digestion, 70.8 mg of insoluble
material and 9.1 mg of soluble material, over 10,000 dalt.
were recovered, representing a 68.3% recovery of the
starting material.
Total recovery of material from all enzymatic
treatments of GBM resulted in 91.3 mg of insoluble GBM
and 233.65 mg of soluble material, representing a 70%
recovery of the starting material.
A 200 mg pool of separate samples of SCM previously
extracted by treatment with either sodium deoxycholate,
2-chloroethanol, or Triton X-100 was digested with 2.0 mg
of trypsin in 20.0 ml of 0.07 M phosphate buffer, pH 8.1.
Following this, 48.6 mg of SCM greater than 10,000 dalt.
was recovered, representing a 24.3% recovery of the starting
material.

,.
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A 36.4 mg sample of proteose was digested with
sialidase after which 29.4 mg of material was recovered.
The direct Ehrlich's method (45) was used to determine
the sialic acid content of the starting materia1 (9.4 mg/
100 mg).

After the direct Ehrlich's method was used to

determine the sialic acid content of the digested material
(1.68 mg/100 mg), it was determined that 82.1% of the sialic
acid was cleaved from the proteose preparation.

c.

DEAE Cellulose Chromatography of Trypsin Soluble
GBM
Tubes from the appropriate fractions, as determined

by examination of the recorded ultraviolet absorption peaks
(Fig. 1), were pooled, dialyzed against distilled water,
and lyophilized.

Fraction I yielded 15.9 mg of material,

Fraction II, 7.55 mg, Fraction III, 4.3 mg, and Fraction IV,
13.2 mg.

Thu~

approximately 40% of the starting material

of 100 mg was recovered.
D.

Amino Acid Analyses
Table 3 contains data for the amino acid composi-

tion of the fractions resulting from the digestion of SCM
and GBM by trypsin and also for the trypsin solubilized GBM
)10,000 dalt. Sepharose innnunoadsorbent.

Table 4 contains

data for the amino acid composition of GBM-Sepharose, RGG-
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Fig. 1. DEAE cellulose chromatography of trypsin
solubilized GBM, of m. w. greater than 10,000 dalt.
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Sepharose, and BGG-Sepharose.
Amino acid analysis recorded in Table 3 revealed
the absence of hydroxylysine and hydroxyproline in SCM.
Half-cystine was the amino acid in lowest concentration
(1.62 mg/100 mg), while glutamic and aspartic acids were
in the highest concentration (16.7 and 14.3 mg/100 mg,
respectively).

Hexosamine was present in the trypsin

solubilized SCM>l0,000 dalt. fraction.
All GBM fractions obtained by trypsin digestion of
whole GBM contained hydroxylysine and hydroxyproline, as
recorded in Table 3.

With the exception of the

10,000

fraction, hydroxyproline was the amino acid of highest
concentration in the GBM fractions (trypsin resistant GBM14.9 mg/100 mg, )3,500(8,000-16.4 mg/100 mg, >8,000(i0,00015.1 mg/100 mg).

Glycine was the amino acid of highest

concentration (14.4 mg/100 mg) in the

~10,000

fractions.

In general, glycine and hyroxyproline were the two amino
acids of highest concentration in all the GBM fractions.
Glutamic acid was also uniformly of high concentration in
all GBM fractions.

Methionine was the amino acid of lowest

concentration in two of the GBM fractions (trypsin resistant
GBM-0. 91 mg/100 mg, )8, 000(10, 000-0. 79 mg/100 mg).

In the

r.f.
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)3,500(8,000 and )10,000 fractions, half-cystine (0.95 mg/
100 mg) and histidine (1.33 mg/100 mg) were the respective
amino acids in lowest concentration.

Hexosamine was present

in all CBM fractions except the trypsin resistant fraction.
When comparing the amino aci.d analysis of the trypsin sblubilized GBM )10,000 fraction to the amino acid
analysis of the homologous Sepharose immunoadsorbent recorded in Table 4, no amino acid was present in an equivalent
concentration.

As a possible explanation for this discre-

pancy, perhaps a select population of molecules from the
original antigen population were preferentially bound to the
Sepharose, thus changing the mg/100 mg contribution of individual amino acids.

Since protein molecules theoretically

bind to Sepharose throughE-amino groups of their lysine
residues (1), the higher concentration of lysine in the
irmnunoadsorbent (4.47

mg/~00

mg), as compared to the ori-

ginal antigen preparation (2.00 mg/100 mg) is in agreement
with this theory.
As recorded in Table 4, significant differences
(±5%) in umol/100 umol concentration of amino acids occur
between unused and used samples of the GBM immunoadsorbent
(histidine, arginine, glutamic acid, alanine, valine, and
methionine), between unused and used samples of the RGG
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immunoadsorbent (lysine, aspartic acid, threonine, serine,
proline, alanine, valine, methionine, leucine, tyrosine,
and phenylalanine), and unused and used samples of the BGG
immunoadsorbent (histidine, arginine, aspartic acid, serine,
proline, half-cystine, glycine, valine, methionine, isoleocine, leucine, and tyrosine).

There were gross differ-

ences between mg protein/ml gel between used and unused
preparations of the RGG irnrnunoadsorbent (.0.91 mg) and the
BGG irnmunoadsorbent (1.58 mg).

The difference in mg pro-

tein/ml gel for the GBM irnrnunoadsorbent was slight (0.04 mg).
The values for mg protein/ml gel of unused Sepharose preparations recorded in Table 4 for GBM-Sepharose (0.26), RGGSepharose (0.70), and BGG-Sepharose (1.44) differ considerably from the mg protein/ml gel recorded in Table 5 for
GBM-Sepharose (1.83), RGG-Sepharose (4.63), and BGG-Sepharose (4. 34).
E.

Affinity Columns
Initial work with the affinity columns concerned

the feasibility of developing a method for the determination
in sera concentrations of antibody specific for the antigen
bound to the column.

Ten ml volumes of Sepharose were

coupled with RGG, BGG, HSA, and BSA antigens.

Table 5

Table 3.

Composition of SCM and GBM preparations in mg/100 mg amino acids.
Trypsin
solubilized
SCM
10,000 dalt.

Trypsin
resistant

4.28

2.12
2.07
1.43
6.56
7.96
14.9
2.94
4.04
11.5
8.15
1.77
14.2
5.66
1.84
0.91
2.88
6.1
1.96
3.34
0.62

·GEM

Amino Acid
Lysine
Hydroxylysine
Histidine
Arginine
Aspartic Acid
Hydroxyproline
Threonine
Serine
Glutamic Acid
Praline
Half Cystine
Glycine
Alanine
Valine
Methionine
Isoleucine
Leucine
Tyrosine
Phenylalanine
Amide-nitrogen*
Hexosamine

1.77
2.98
14.3
5.74
4.66
16.7
4.02
1.62
5.10
6.29
6.73
1.77
7.42
9.87
3.58
5.10
0.309

+

* Reported as urnol/190 urnol ·
**,Off scale

Trypsin solubilized GBM
)3,500 dalt.

<B,ooo

>8,ooo

<10,000

d lt
:>10,000 dalt.
a • ')-10,000 dalt.
Sepharose

4.02
2.18
2.91
6.52
9.58
16.4
3.16
3.54
10.4
4.80
0.95
11.2
4.36
1.54
3.8
3.68
5.86
1.86
3.28
0.18

2.68
3.52
2.68
6.00
9.37
15.1
3.76
4.15
11.4
. 5. 30
0.921
15.8
3.54
2.65
0.79
2.60
5.50
1.44
2.68
0.194

2.00
3.20
1.33
3.93
6.9
12.4
6.53
3.64
11.0
5.44
1.60
14.4
5.19
2.85
1.49
4.04
7.25
2.58
4.17
0.234

4.47
2.93
1.66
8.22
9.98
15.9
3 .02
4.82
16.0
8.64
0.84
0.5
3.62
3.95
1.32
4.69
8.45
1.47
4.89
0.5

+

+

+

+
~

°'

Table 4.

Composition of antigen-Sepharose 4B preparations in
urnol/100 urnol amino acids.

Antigen Description

Trypsin Solubilized
GBM>l0,000 dalt.

Column Designation

Unused

used

Unused

Used

Unused

Used

3.78
2.19
1.31
6.67
15.4
9.29
4.67
5.69
13.4
9.29
0.42
O.S.*
5.97
4. 20
0.65
4.43
7.98
1.03
3.64

3.59
2.39
1.93
3.63
15.8
8.49
5.44
6.68
11.8
8.42
0.69
O.S.*
9.46
5.44
0.35
4.28
7.68
0.89
3.01

7.89

5.61

5.26

5.00

1.12
3.06

0.91
3 .12

0.64
3.48

1.87
2.91

9.87
8.52
9.55
12.6
7.01
2.36
7.06
8.27
6.07
0.80
2.39
7.48
2.42
3.27

7.78
7.50
18.2
13.3
5.33
2.18
7.01
10.8
7.46
0.18
2.10
5.64
1.89
2.07

8.75
11.4
12. 5
9.92
7.30
2.11
7.96
6.56
9.22
1.00
2.48
6.34
2.40
2.31

7.09
11.94
10.1
10.4
8.43
1.75
9.58
6.04
7.68
0.80
3.16
7.26
4.14
2.28

0.26

0.30

0.70

1.61

1.44

3.02

RGG

BGG

Amino Acid
Lysine
Hydroxylysine
Histidine
Arginine
Hydroxyproline
Aspartic Acid
Threonine
Serine
Glutamic Acid
Proline
Half Cystine
Glycine
Alanine
Valine
Methionine
Isoleucine
Leucine
Tyrosine
Phenylalanine
mg antigen/ml gel
* Off Scale
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lists the umol of antigen theoretically bound to the Sepharose during the coupling stage for RGG, BGG, HSA, BSA, and
the other antigens coupled to Sepharose for use in the
project.
The three immunoglobulin Sepharose immunoadsorbents
showed the highest binding of antigen during the coupling
· stage, with HGG having essentially all of the added ligand
(5.0 mg/ml) bound during the coupling stage.

The least

amount of antigen bound to any one column was 0.32 mg/ml
on the proteose #1 immunoadsorbent.

Of those antigens for

which more than one column was made (BSA, proteose, siali<lase treated proteose), the BSA immunoadsorbents gave the
best reproducibility in binding (BSA #1, 1.37 mg/ml and BSA
#2 1.08 mg/ml) while the two proteose immunoadsorbents
displayed the wprst reproducibility in binding (proteose
#1, 0.32 mg/ml and proteose #2, 1.54 mg/ml).

Of note was

the equivalent amount of antigen bound for GBM
(1.83 mg/ml) and SCM

10,000 dalt.

10,000 dalt. (1.84 mg/ml).

Figure 2 is a typical "run" of an antiserum over
an affinity column, with effluent and eluted fractions
labelled appropriately.

By obtaining the

o.

D. of the

reconstituted eluted fraction, and knowing the initial
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Table 5.

Quantity of antigen bound to Sepharose
4B columns

Antigen

Antigen bound/ml packed
Sepharose 4B
umol

(mg)

BSA #1

0.02

(1.37)

BSA #2

0.02

(1.08)

HSA

0.04

(2.90)

BGG

0.03

(4.34)

RGG

0.03

(4.63)

HGG

0.03

(5.00)

Protease #1

0.01

(0.32)

Protease #2

0.04

(1.54)

Sialidase treated prote·ose #1

0.03

(1.27)

Sialidase treated protease #2

0.05

( 2.14)

Trypsin solubilized GBM
>10,000 dalt.

(1.83)

Trypsin solubilized SCM
>10,000 dalt.

(1.84)
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volume of antiserum added to the column, one could theoretically obtain a reasonable value for the concentration in
the serum of the antibody specific for the antigen coupled
to the Sepharose.
the

o.

No consistent attempt was made to measure

D. of the eluted fraction inunediately after its

collection due to the large volume (12-20 ml) of the fraction and the subsequent questionable results which were
often obtained.

Data recorded in Table 9 on protein con-

centrations of eluted fractions depict the problem (compare
final concentrations vs. concentrations determined at elution).

The extinction coefficient for RGG was determined

experimentally using known concentrations of RGG isolated
by DEAE Sephadex chromatography.

Unfortunately, the data

for the experiments was collected over a period of months.
In that time span, it was discovered that the spectrophoto- .
meter was not giving consistent readings.

As a result, a

Beckman Spectrophotometer Model DUR (Beckman Instruments,
Inc., Fullerton, CA) had to be used for some of the readings.
As a ·consequence of these mechanical difficulties, the
values reported in Table 6 are not and cannot be considered
true representations of antibody concentrations in sera.
However, those data listed as being obtained on the same
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date are of value in reporting relative antibody concentration between samples, since they were determined under identical experimental conditions.
Inconsistent results· were obtained for concentrations of antibody in eluted fractions from experiments involving passage of successive equal volumes of antiserum
over the same gel bed.

Examples are two successive runs

of 1.0 ml of anti-RGG serum over RGG-Sepharose (4/22/76),
yielding 1.47 mg/ml and 2.34 mg/ml; and two .successive
runs of 1.0 ml of anti-BGG serum over BGG-Sepharose
(6/14/76), yielding 0.27 mg/ml and 0.60 mg/ml.

Inconsis-

tent results were also obtained from experiments in which
successive runs of increasing volumes of antisera were
passed over the same innnunoadsorbent.

Examples are:

anti-

RGG serum over the RGG-Sepharose, 1/29/76 (1.0 ml-1.97 mg/
ml, 1.5 ml-2.34 mg/ml) and 1/30/76 (2.0 ml-2.52 mg/ml, 3.0
ml 2.04 mg/ml); sheep anti-HSA serum over HSA-Sepharose,
4/16/76 (2.0 ml-1.02 mg/ml, 3.0 ml-1.78 mg/ml) and 5/19/76
(1.0 ml-2.04 mg/ml, 2.0-1.5 mg/ml); anti-BGG serum over
BGG-Sepharose, 4/29/76 (1.0 ml-0.36 mg/ml, 2.0 ml-0.56
mg/ml); and finally anti-HLC serum over HGG-Sepharose,
5/10/76 (1.0 ml-0.48 mg/ml, 5.0 ml-0.57 mg/ml).

r

I
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\
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Fig. 2. Typical affinity chromatogram. Figure depicts
successive runs of 0.5, 1.0, and 2.0 ml of a rabbit anti-BGG serum
over a BGG-Sepharose 4B column. Note run through (effluent) and
eluted fractions.
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Table 6.

Golumn
Antigen
RGG

HSA

BGG

Antibody concentrations of eluted fractions
from affinity chromatography of antisera on
Sepharose 4B antigen columns.
Eluted Antibody
Concentration"''

Date

Volume( ml)

1/29/76
1/29/76
1/30/76
1/30/76
4/22/76
4/22/76

1.0
1.5
2.0
1.0
1.0

1.97
2.34
2.52
2.04
1.47
2.34

Sheep
antiHSA

1/ 9/76
4/16/76
4/16/76
5/19/76

2.0
3.0
2.0

1.77
1.02
1.78
1.51

Rabbit
antiBGG

4/29/76
4/29/76
6/14/76
6/14/76
6/14/76

1.0
2.0
1.0
1.0
2.0

0.36
0.56
0.27
0.60
0.58

5/10/76

1.0

0.90

5/10/76
5/10/76

1.0
5.0

0.48
0.57

11/21/75
11/26/75
12/ 6/75
12/10/75

9. 0* 1i:

2.64

14.0**
5. 0*"''
5.0**

1.53

Antiserum
Rabbit
antiRGG

Rabbit
antiHGG

3. o-i:*

HGG
Rabbit
antiHLC

BSA

Rabbit
antiBSA

2.81
1.80

*In mg/ml of the original volume of sera passed over
the column.
**Indicates precipitation in ring tests of the effluent
fraction vs. antigen
'

r
.
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Data obtained from experiments involving passage
of an anti-BSA serum over the BSA-Sepharose innnunoadsorbent
was obtained on different days.

The problems mentioned in

Section H of Materials and Methods concerning the spectrophotometer had not occurred at the time the data was collected.

Therefore, the eluted antibody concentration

obtained for the four experiments using the same BSASepharose gel bed and the same anti-BSA serum are comparable to each other.

The concentrations are:

11/21/75,

9.0 ml-2.64 mg/ml; 11/26/75, 14.0 ml-1.53 mg/ml; 12/6/75,
5.0 ml-2.80 mg/ml; and 12/10/75, 5.0 ml-1.88 mg/ml.
Precipitin ring tests of the effluent fraction of each
experiment vs. BSA were positive.
1.

Determination of Specificity of Eluted Antibody.

In

ring tests, goat anti-RGG serum precipitated with the
eluted fractions of rabbit antisera and ring tests consisting of the eluted fraction vs. a solution of the antigen
coupled to the respective Sepharose column also resulted
in precipitation.
As another test of the specificity of the eluted
antibody, 5.0 mg samples of anti-BSA antibody, isolated
from the previous affinity column runs of a rabbit anti-BSA
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serum over BSA-Sepharose columns, were dissolved in 5.0
ml of phosphate buffer, pH 7.5.

Duplicate samples were

run over BSA-Sepharose columns and HSA-Sepharose columns.
The results are shown in Figs. 3A and 3B.

Determinations

of antibody concentrations using O. D. were not attempted;
instead the number of squares under each curve were tabulated and reported in Table 7.
Passage of the anti-BSA solution over the BSASepharose immunoadsorbent resulted in the following areas
under curves:

Fig. 3A. effluent peak 1-78, eluted peak

1-1096; effluent peak 2-75, eluted peak 2-894.

Passage of

the anti-BSA solution over the HSA-Sepharose immunoadsorbent resulted in the following area under curves:

Fig. 3B.

effluent peak 1-1195, eluted peak 1-201; effluent peak
2-1067, eluted peak 2-307.

Total area under curves in

Fig. 3A was 2143 square units; under curves in Fig 3B was
2770 square units.
2.

Effect of the Removal of Sialic Acids from Proteose

Antigen on the Binding of the Antigen to Sepharose.

Com-

parison of Affinity Chromatography Using Proteose-Sepharose
and Proteose(sialidase treated)-Sepharose Columns.

Siali-

dase treated protease and untreated protease were bound to

r
.
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Table 7.

Evidence for the specificity of antibody in
eluted fractions from affinity chromatography of antisera. Comparison of areas under
curves resulting from affinity chromatogra- ·
phy of 1.0 mg/ml solutions in PBS of antiBSA antibody isolated from affinity chromatography of an anti-BSA serum over BSASepharose columns.

Curve Designation

Area Under Curve*

Eluted Fraction
Fig. 3.

(A. BSA-Sepharose)
1096
894

Peak 1.
Peak 2.
Fig. 3.

(B. HSA-Sepharose)

Peak 1.
Peak 2.

201
307

Effluent Fraction
Fig. 3.

(A)

Peak 1.
Peak 2.
Fig. 3.

78
75
(B)

Peak 1.
Peak 2.
*l square

1195
1067

= 1 square unit
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Fig. 3A. Result of passing successive 5.0 ml samples
of a 1.0 mg/ml solution of anti-BSA antibody in 0.5 M phosphate
buffer, pH 7.5 over a BSA coupled Sepharose 4B affinity column.

V1

Fig. 3B. Result of passing successive 5.0 ml samples
of a 1.0 mg/ml solution of anti-BSA antibody in 0.05 M phosphate
buffer, pH 7.5 over a HSA coupled Sepharose 4B affinity column.
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separate 10.0 ml volumes of packed Sepharose.

The exper-

iment was done in duplicate, and the umol of antigen bound/
ml of packed Sepharose for each column are given in Table S.
Relative antibody concentrations of eluted fractions from
experiments in which samples of the same rabbit antiproteose serum were passed over the columns are given in
Table 8, along with theoretical combining ratios of antibody
with column antigen sites.
The data is divided into two groups, I and II,
since the removal of sialic acids by treatment of protease
with sialidase was not determined for the antigen preparation used in construction of the sialidase-proteose #1
Sepharose immunoadsorbent.

However, the digestion was

carried out in exactly the same manner as the digestion of
the protease used for sialidase-proteose #2, of which the

% release of sialic acids was reported in Section B of
this chapter.

Since the protease for both digestions was

obtained from the same batch of material, the sialic acid
content of the two preparations would not be expected to
differ significantly.

In addition, data for sialidase

protease #1 and protease #1 were obtained on the same day,
while the data for sialidase protease #2 and protease #2
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were obtained on a different day.

Therefore, a compari-

son between the figures of the two sections is not valid.
However, in both groups of data, combining ratios for the
proteose-Scpharose immunoadsorbcnts (Protease #1:

.081

and .076 umol antibody/umol antigen; Proteose #2:

.017,

.021, and .017 umol antibody/umol antigen) were greater
than combining ratios for proteose(sialidase treated)Sepharose immunoadsorbents (Sialidase-Proteose #1:

.024

and .011 umol antibody/umol antigen; Sialidase-Proteose
#2:

.013 and .011 umol antibody/umol antigen).

Referring

to Table S, the umol of antigen bound to the proteoseSepharose immunoadsorbents (Proteose #1-0.03 umol/ml gel,
Proteose #2-.01 umol/ml gel) is less than the umol of antigen bound on proteose(sialidase treated)-immunoadsorbents
(sialidase treated proteose #1-0.04 umol/ml gel, sialidase
treated proteose #2-0.03 umol/ml gel).
F.

Analysis of Eluted Fractions Utilizing Immunoelectrophoresis.
Fig. 4 depicts results of immunoelectrophoresis

of the eluted fractions resulting from affinity chromatography of rabbit anti-BSA and goat anti-RGG sera over
homologous antigen-Sepharose columns. ·

···~~-""''~~·~Pliif\UJ#M

Table 8.

Comparison of affinity chromatography of a rabbit
anti-protease serum on proteose-Sepharose and
proteose(sialidase treated)-Sepharose columns.
Serum Sample
Volume(ml)

Eluted Antibody
Concentration*

Combining Ratio
(umol antibody/
umol antigen)

Sialidase-proteose #1

5.0

0.54

.024

Sialidase-proteose #1

5.0

0.24

.011

Proteose #1

5.0

0.61

.081

Proteose #1

5.0

0.57

.076

Sialidase-proteose #2

1.0

0.41

.011

Sialidase-proteose #2

3.0

0.49

.013

Proteose #2

1.0

0.52

.017

Proteose #2

2.0

0.64

.021

Proteose #2

3.0

0.50

.017

Colu11ll1 Description

I.**

II.

0\

*Expressed as mg/ml of the original antiserum
**% release of sialic acid not. determined

N

Jjj
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A single precipitin arc was observed between antiWRS (trough #3) and a sample of a pool of all eluted antiBSA fractions (well B) recorded in Table 6.

Since the arc

is in a corresponding position to the precipitin arc
between anti-WRS (trough #3) and RGG (well C), the eluted
antibody fraction from affinity chromatography on the BSA
immunoadsorbents is composed solely of RGG.

Further proof

is provided by the equivalent pattern of precipitin arcs
(each pattern composed of two arcs) between anti-RGG
(trough #2) and the pooled eluted anti-BSA fraction (well
B); and between anti-RGG (trough #4) and RGG (well C).
The precipitin arcs formed between anti-WRS (trough #1)
and NRS (well A), and between anti-RGG (trough #2) and NRS
(well A) are included for reference.
The absence of a precipitin arc between anti-RGG
(trough #4) and the eluted goat anti-RGG fraction tends
to lessen the likelihood that column bound antigen was
shed during the elution step on the RGG immunoadsorbent •.
It should be noted that the goat anti-RGG serum was passed
over a RGG-Sepharose imnrunoadsorbent, and that the RGG used
in the construction of the column is from the same source
as the RGG present in well

c.

A precipitin arc was also
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Well:
Trough:

1

c

B

A

2

3

D

4

5

Fig. 4. Inununoelectrophoresis of eluted antibody
fractions from affinity chromatography of rabbit anti-BSA
and goat anti-RGG sera over homologous antigen-Sepharose
columns. Well: A. NRS, B. eluted anti-BSA, C. RGG
(identical arttigen preparation coupled to Sepharose),
D. eluted anti-RGG. Trough: 1. anti-whole rabbit serum
(WRS), 2. anti-RGG, 3. anti-WRS, 4. anti-RGG, 5. artti-GGG.
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formed between anti-GGG (trough #5) and the eluted goat
anti-RGG fraction (well D).
G.

Determination of Antibody Activity in Effluent
and Eluted Fractions Using Hemagglutination Assays.
With the use of antigen coated RBC it was

possibl~

to (i) provide a more sensitive method than the ring test
for determining antibody saturation of antigen sites by
comparing the titer of the effluent fraction to the titer
of the original serum; and (ii) determine if the observed
decrease in hemagglutinating activity observed in the effluent fraction could be accounted for by a corresponding
increase in antigen specific hemagglutination activity in
the eluted fraction.

Data are recorded in Tables 9, 10,

11, 12, 13, 14, 15, and 16.
a titer was not determined; a

Double dashed lines indicate
11

0 11 indicates a titer of O.

When observing Tables 9-16, the reader must give
careful consideration for titers of standard serums (i.e.
a titer of the serum from which the original sample run
over the affinity column was obtained) when interpreting a
given set of figures.

Not all of the titers were determined

on the same day or on the same batch of antigen coated RBC.
The term "serum affinity sample" shall refer to the effluent
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and eluted fractions collectively, when discussing the
number of linear twofold dilutions carried out on the
effluent and eluted fractions.
Data for titers was also reported in log
dilution.

2

of the

A decision was made to report the titers by

this method after it was decided that the reciprocal of
the dilution was not the best method for comparing the
hemagglutination activity of effluent and eluted titers.
For example, suppose a serum has a hemagglutination titer
of 32,000.

After passing a volume of the serum over an

affinity column, the effluent fraction was determined to
have a titer of 8,000 and the eluted 4,000.

From compar-

ison of the titers reported as reciprocals of dilutions,
it may appear that a great deal of hemagglutinating activity has been lost.

However, the log

2

of the dilution of

the original serum is 5, meaning that a L:l,000 dilution
of serum had to be serially diluted out in twofold fashion
5 times before all hemagglutinating activity disappeared.
Using the same reasoning, the effluent fraction was diluted
out twice, indicating that again a fivefold dilution of
the serum was necessary to remove the hemagglutinating activity.

Therefore, the log

2

of the sample dilution pre-
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sents a more accurate description of the hemagglutinating
activity of the effluent and eluted fractions.
As a specific example, the titer of the standard
serum on the batch of HSA coated RBC used to titer the
2.0 ml sample from 4/16/76 recorded in Table 9 was 28,800.
This means that a 1/1,000 dilution of the serum was diluted in twofold fashion approximately 4.75 times (log
16,000

= 4, log 2 32,000 = 5) to obtain the titer.

2

The

titers of the effluent and eluted fractions of the 4/16/76
sample were 5,600 (2.5) and 3,200 (1.5) respectively.
Therefore, a total of four twofold dilutions were needed
to obtain a titer on a 1/1,000 dilution of the serum
affinity sample.

The titer of the standard serum on the

batch of HSA coated RBC usedcto titer the NSS reconstituted eluted fraction of the 2.0 ml sample from 4/16/76
was 18,000, roughly equivalent to a 1/1,000 dilution of
the serum being diluted out four times.

The titers of the

effluent (800, .5) and NRS reconstituted eluted (3,200,
1.5) fractions indicate that effectively a 1/1,000 dilution
of the serum affinity sample was diluted in twofold fashion
twice to obtain the titer (.5 + 1.5

= 2).

Therefore, the

titers determined on non-reconstituted eluted and respec-
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tive effluent fraction from the 2.0 ml sample from 4/16/76
show a better recovery of hemagglutinating activity (4/4.75)
as compared to the NSS reconstituted eluted fraction and
respective effluent fraction (2/4).
However, the two serum affinity samples from
5/19/76 which were NSS reconstituted, show a greater recovery of hemagglutinating activity than the respective
non-reconstituted serum affinity samples (NSS reconstituted:
1.0 ml-2/4, 2.0 ml-4/4; non-reconstituted:
2.0 ml-4.5/7).

1.0 ml-1.57,

For the 3.0 ml sample from 4/16/76, both

the non-reconstituted (6.5/4.75) and NSS reconstituted
(6/4) serum affinity samples show a higher hemagglutinating
activity than the respective standard serums.

This pro-

bably represents an error of reconstituting the eluted
antibody in too small of a volume of BBS, effectively
concentrating the antibody and thereby increasing the
titer of the eluted fraction.
Of note in Table 12 was the vast improvement in
recovery of hemagglutinating activity shown in the NRS
reconstituted serum affinity samples from 4/29/76 over the
respective non-reconstituted fractions (NRS reconstituted:
1.0 ml-2.5/4, 2.0 ml-4.5/4; non-reconstituted:

1.0 ml-
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1.5/9, 2.0 ml-1/9).

Once again, a slight error in recon-

stituting the eluted antibody fraction of the 2.0 ml sample
may have occurred (or possibly when reconstituting with
NRS), indicating the importance of precise technique when
reconstituting the fractions.

NRS reconstituted serum

affinity samples of the goat anti-RGG serum from 5/22/76 recorded in Table 14 show a similar improvement in recovery
of hemagglutinating activity over, non-reconstituted fraction (NRS reconstituted:
non-reconstituted:

I.

I.

1.0 ml-3/3, II.

1.0 ml-.5/5.5, II.

1.0 ml-2/3;

1.0 ml-.5/5.5).

All NRS reconstituted affinity samples recorded in Table 15
displayed improvement in recovery of hemagglutinating activity over non-reconstituted fractions, both for the goat
anti-RGG serum samples from 5/22/76 (NRS reconstituted:
1.0 ml-2/3.5, II.

1.0 ml-4.75/3.5-possibly another recon-

stitution error; non-reconstituted:
II.

I.

I.

1.0 ml-.5/2.5,

1.0 ml-.5/2.5) and the anti-BGG serum from 5/23/76

(NRS reconstituted:

8/9.5; non-reconstituted-2.5/5).

In those instances previously mentioned where errors
were made in reconstitution of eluted antibody fractions
(3.0 ml from 4/16/76 in Table 9, 2.0 ml from 4/29/76 in
Table 12, II.

1. 0 ml from 5/ 22/76 in Table 15), with the
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exception of the serum affinity sample of 3.0 ml from
4/16/76 recorded in Table 9, it is doubtful that the increase in hemagglutinating activity of the NRS reconstituted
eluted fraction over the non-reconstituted eluted fraction
could be explained on the sole basis of the slight error
that may have been made during reconstitution (either with
BBS of the original lyophilized material or NRS of the
buffered eluted antibody solution).

The NRS (also NSS in

Table 9) used to reconstitute buffered eluted fractions
never contributed significantly to the titer of the reconstituted eluted fractions, as shown by titers recorded in
all tables containing data on hemagglutination assays (with
the exception of Table 16, since the effluent fraction was
used to reconstitute the eluted antibody).
The high titers (as compared to standard serums)
of effluent fractions recorded in Table 13, for both NRS
reconstituted.and non-reconstituted serum affinity samples,
indicate that the RGG-Sepharose preparation was a very poor
immunoadsorbent.

Of note is the essentially complete re-

covery of hemagglutinating activity in non-reconstituted
serum affinity samples from 1/30/76 (3.75/3.75), 1/31/76
(3.75/3.75) and the 1/5 ml sample from 1/29/76 (3.25/3.75).

r
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The respective NRS reconstituted serum affinity samples
displayed a slight decrease in recovery of hemagglutinating
activity (1/30/76:
1/29/76:

5/6, 1/31/76:

5/6, 1.5 ml sample from

5/6).
Data recorded in Table 16 demonstrate the result

of concentrating the eluted antibody fraction during the
buffer reconstitution step.

Increases in titers were ob-

served in all eluted fractions (as compared to standard
serums) assayed on the various antigen preparations with
the exception of the assay on trypsin-carbohydrase solubilized GBM >10,000 dalt. coated RBC (on which no titer for
the standard serum, effluent, or eluted fractions was
observed).

Examples are:

trypsin solubilized GBM >3,500

<8,000 dalt. coated RBC (eluted:

20,800/standard serum:

3,584), DEAE fraction I of trypsin solubilized GBM >10,000
dalt. coated RBC (eluted:

260/standard serum:

148), and

trypsin solubilized GBM >10,000 dalt. coated RBC (eluted:
1,040/standard serum:

416).

It was found that RGG and BGG could only be coupled
to rabbit RBC, since attempts to couple RGG and BGG to
human RBC always resulted in preparations that autoagglutinated.

Also, it was necessary to use the supernatant
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resulting from the first attempt at coupling rabbit RBC
with RGG or BG9 to couple a second batch of cells, since
the first preparation invariable autoagglutinated.

HGG

and SCM were not successfully coupled to either human or
rabbit RBC.

HGG preparations autoagglutinated; SCM pre-

parations never demonstrated a titer with any SCM or GBM
antiserum used (including the eluted fraction from the GBM
serum described in section L of Materials and Methods).
All antigen coated cells were stored at

4°c.

Antigen

coated cells which were frozen and then thawed for use
in assays consistently autoagglutinated.
H.

Fluorescent Antibody Tests.
Comparison of indirect fluorescent antibody tests

revealed that the concentrated eluted fraction of the antiPGT HUGL II serum gave more intense glomerular staining
than the original serum.

Of additional proof of effective-

ness of the trypsin solubilized GBM >10,000 dalt. inununoadsorbent was the finding that the glomerular staining
intensity of the effluent fraction was comparable to NRS
and normal saline controls, indicating complete removal of
specific antibody from the serum.
I.

Production of Hemorrhagic Necrosis in Guinea Pigs.

.. ~
Table 9.

Identification
Serum:

Inununoadsorbtion of sera on a HSA coupled Sepharose
4B column. The assessment of recovery of antibody
activity as measured by hernagglutination of HSA
coated erythrocytes.
Protein concentration of
eluted fraction (mg/ml)

Hernagglutination Titer
NSS Reconstituted

Sheep-anti-HSA
At elution

Final

Volume

Date

5. 0 ml

1/ 9/76

1.80

--

1.0 ml

4/16/76

1.48

...-

2. 0 ml

4/16/76**

0.80

3.0 ml

4/16/76**

1. 0 ml
2. 0 ml

Effluent Eluted

Effluent Eluted

--

--

400

2,560
(l)*

1.02

5,600
( 2. 5)

3,200
(1. 5)

800
(. 5)

3,200
(1. 5)

0.68

1.78

8,400
( 3)

12,800
( 3. 5)

3,600
( 2)

16,640
(4)

5/19/76***

1.88

2.04

1,600
(1)

1,300
(. 5)

1,800
(1)

1,600
(1)

5/19/76***

1.27

1.51

6,400
( 2. 5)

4,200
( 2)

800
(. 5)

13,440
(3. 5)

*Number in parenthesis indicates logt of the dilution of the given sample
**Titer of standard serum = 128,000 ( )
***Titer of standard serum= 28,800 (4.75)
For all NSS reconstituted fractions, the titer of the standard serum was 18,000 (4).
The NSS had a titer of 4.

......i
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Table 10.

Protein concentration of
eluted fraction (mg/ml)

Identification
Serum:

pr~t:':~:,-:=·-w;"'*'¥\llJ4iiiC!J ~

Immunoadsorbtion of sera on a
Sepharose 4B column. The assessment of recovery
of antibody activity as measured by hemagglutination
of proteose coated erythrocytes.

Hemagglutination Titer

NRS Reconstituted

Rabbit-anti
proteose

Volume

Date

I.
5.0 ml

1/15/76

II.
5.0 ml

1/15/76

1.0 ml

5/12/76

2.0 ml

At elution

Final

Effluent* Eluted*

Effluent Eluted

--

• 61

8

40

40**

1,680?';-*
(1)

--

• 57

32

40

40**

3 360**
' 5)
(1.

1.33

.695

--

5/12/76

1.08

.654

1.0 ml

6/21/76

1.19

.52

---

---

2.0 ml

6/21/76

1.99

.64

3.0 ml

6/21/76

1.43

.so

*Titer
**Titer
**;\-Titer
Titer
Note:

.

40***

60--;':7:*

640,~**

420*'"''~

--

520*;\-*

2' 56Q;\-**
(1. 5)

--

--

560***

3 200***
' 5)
(1.

--

--

420***

3' 200*;\-*
(1. 5)

of standard serum = 500
of standard serum = 16,000 (4)
of standard serum = 52,000 (5.5)
of NRS = 2
Erythrocytes used in the NRS reconstituted series were coated
t.1H-h sia1 idase treated proteose.

-.....!

+:--

~

Table 11.

Identification
Serum:
Volume

Immunoadsorbtion of sera on a proteose (sialidase tre~ted)
coupled Sepharose 4B column. The assessment of recovery
of antibody activity as measured by hemagglutination of
proteose (sialidase treated) coated erythrocytes.
Protein concentration of
eluted fraction (mg/ml)

Hemagglutination Titer
NRS Reconstituted

Rabbit-antiProteose
Date

At elution

Final

Effluent* Eluted*

Effluent Eluted

I.
5.0 ml

1/16/76

0.54

0

20

40**

420**

II.
5.0 ml

1/16/76

0.24

0

20

20**

1,040**
(. 5)

1.0 ml

5/11/76

120**
Column #2

1.0 ml

6/23/76

0.82

0.49

--

--

3.0 ml

6/23/76

0.68

0.41

--

--

*Titer of standard serum = 500, using non-sialidase treated glycoprotein
coated erythrocytes.
**Titer of standard serum = 16,000 (4)
***Titer of standard serum= 5,200 (2)
Titer of NRS = 2

640*-1:*

180~'>"*-l~

1,280***
(. 5)

8QQ1\-*1\"'

(. 5)

'-1

V1

..,,...
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Table 12.

Identification
Serum:

Immunoadsorbtion of sera on a BGG coupled Sepharose
4B colurrm. The assessment of recovery of antibody
activity as measured by hemagglutination of BGG
coated erythrocytes.
Protein concentration of
eluted fraction (mg/ml)

Hemagglutination Titer
NRS Reconstituted

Rabbit-anti-BGG

Volume

Date

At elution

Final

Effluent* Eluted*

0.5 ml

4/29/76

1.0 ml

4/29/76

0.36

16

2,600
(1. 5)

2.0 ml

4/29/76

0.56

1,280

800
(. 5)

(. 5)

Effluent Eluted
90**

20**

80**

6 720**
' 5)
( 2.

140*** 20 800***
' 5)
(4.

1.0 ml

6/12/76

4.04

0.27

1, 600;~**
(1)

1.0 ml

6/14/76

6.14

0.60

800;~**

2.0 ml
*Titer
**Titer
***Titer
Titer

6/14/76
of
of
of
of

4.16

standard serum = 512,000 (9)
standard serum = 16,000 (4)
standard serum = 52,000 (5.5)
NRS = 4

0.58

(. 5)

1, 600;~**
(1)

1, 6007'"**
(1)

1, 60071"**
(1)

'-l
CJ'\

Table 13.

Identification
Serum:

Protein concentration of
eluted fraction (mg/ml

Hernagglutination Titer

Goat-anti-RGG

Volume

Date

3. 0 ml

1/30/76

2.0 ml

Im.-nunoadsorbtion of sera on a RGG coupled Sepharose
4B column. The assessment of recovery of antibody
activity as measured by hernagglutination of RGG
coated erythrocytes.

NRS Reconstituted
At elution

1/31/76

Final

Effluent* Eluted*

Effluent** Eluted**

2.04

10,640
(3.25)

800

32,000

10,640
( 3. 25)

800

2.52

1.0 ml

1/29/76

1.97

1. 5 ml

1/29/76

2.37

1. 0 ml

4/22/76

1. 0 ml

4/22/76

1.47
4.00

(. 5)

(. 5)

0

(5)

32,000

640

(5)

116
10,440
(3.25)

400

32,000

0

( 5)

800

2.34

*Titer of standard serum= 14,400 (3.75)
**Titer of standard serum = 64,400 (6)
Titer of NRS = 20
-...J
-...J

Table 14.

Protein concentration of
eluted fraction (mg/ml)

Identification
Serum:

Irrnnunoadsorbtion of sera on RGG and BGG coupled Sepharose
4B columns. The assessment of recovery of antibody activity
as measured by hemagglutination of RGG coated erythrocytes.
Hemagglutination Titer
NRS Reconstituted

Goat-anti-RGG

Column Antigen:
Volume

Date

I.
1.0 ml

5/22/76

BGG
At elution

Final
2.11

Effluent* Eluted*
400

520

Effluent**Eluted**
4,760

720

( 2. 5)

(. 5)

II.

1.0 ml

2.25

5/22/76

400

560

3,360
(1. 5)

Serum:

(. 5)

Rabbit-anti-BGG

Column Antigen:
1.0 ml

1,120

5/23/76

RGG
0.88

20

16

0

0

*Titer of RGG standard serum = 52,000 (5.5); of BGG standard serum= 1,280 (.5)
**Titer of RGG standard serum = 10,640 (3); of BGG standard serum= 160
Titer of NRS = 16
"-J
CX>

r
Table 15.

Protein concentration of
eluted fraction (mg/ml)

Identification
Serum:

Hemagglutination Titer
NRS Reconstituted

Goat-anti-RGG

Colurrm Antigen:
Volume

Immunoadsorbtion of sera on RGG and BGG coupled Sepharose
4B columns. The assessment of recovery of antibody activity
as measured by hemagglutination of BGG coated erythrocytes.

BGG

Date

At elution

Final

Effluent* Eluted*

Effluent**Eluted**

I.
1.0 ml
II.
1.0 ml

Serum:

5/22/76

5/22/76

2.25

800

800

20

20

2,240

3,072

(1)

(1. 5)

3,360

7,168

(1. 5)

( 2. 7 5)

Rabbit-anti-BGG

Colurrm Antigen:
1.0 ml

2.11

5/23/76

RGG
0.88

6,400
( 2. 5)

20

16,640

16,640

(4)

(4)

*Titer of RGG standard serum= 5,600 (2.5); of BGG standard seru.~ = 36,000 (5)
**Titer of RGG standard serum= 13,440 (3.5); of BGG standard serum= 832,000 (9.5)
Titer of NRS = 8

-....J

'°

Table 16.

Irnmunoadsorbtion of an anti-GBM serum on a GBM coupled
Sepharose 4B colurrm. The assessment of recovery of
antibody activity as measured by hemagglutination of
erythrocytes coated with various GBM antigens.

Antigen Description
Trypsin-Carbohydrase solubilized
GBM >10,000 dalt.

Anti-PGT HuGlom II

Effluent*

Eluted'~

0

0

0

3,584

678

20,800

DEAE Fraction I of Trypsin
solubilized GBM
>10,000 dalt.

148

0

260

Trypsin solubilized GBM
>10,000 dalt.

416

2

1,040

Trypsin solubilized GBM
>3,500<8,000 dalt.

*Originally 5.0 ml of anti-PGT HuGlom II was passed over a Sepharose colurrm
coupled with trypsin solubilized GBM 10,000 dalt. The effluent was run
through the column again. The resulting effluent fraction and pooled
eluted fractions were dialyzed and lyophilized as described in section H
of Materials and Methods. The effluent fraction was reconstituted to 5:0 ml
in BBS, 1.0 ml of which was then used to reconstitute the pooled eluted
fractions.
00
0
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Results of the production of hemorrhagic necrosis
in guinea pigs using anti-GBM and anti-SCM sera are recorded
in Table 17.
The antiserum causing the strongest necrotic reaction was anti-SCM #25, which caused a 4+ reaction from
24h-120h.

Other antisera causing strong (at least one 4+

reaction during the course of the experiment) necrotic
reactions include trypsin res. GBM #14, CNBr-SCM-super #18,
PGT-HuGlom II #20, SCM #26, SLS-SCM II #28, SCM #29, and
Pep. Insol. SCM #30.

Antisera causing no visible necrotic

reaction were HuGlom #11 and Pep-CNBr-SCM #15.

Other anti-

sera causing weak (only a + reaction during the course of
the experiments) necrotic reactions include HuGBM #1, SLSGBM #2, PGT-HuGlom III #5, SLS-CNBr-GBM #6, PGT-HuGlom III
#7, CNBr-SLS-SCM #9, SLS-SCM #10, SLS-CNBr-GBM #13, SLS-SCM
II #22, and SCM #23.

NRS caused a positive reaction in one

animal, G. P. I(+ at 72 hand 96h).
Antisera against the same antigen preparation and
causing varying degrees of necrosis include Pep-CNBr-SCM
#3 (G. P. I:

3+ at 120h) and #15 (G. P. IV:

SLS-SCM #4 (G. P. I:

no reaction);

3+ at 120h), #10 (G. P. III:

72h), and #17 (G. P. V:

+at

3+ at 120h); HuGlom #8 (G. P. II:

•
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3+ at 120h), and #11 (G. P. III:
SCM II #22 (G. P. VII:
4+ at 120h).

no reaction); and SLS-

+ at 120h) and #28 (G. P. VII:

Antisera against the same antigenic prepar-

ation causing similar severity of necrosis include:
HuGlorn III #5 (G. P. II:

+ at 120h) and #7 (G. P. II:

+at 96h); SLS-CNBr-GBM #6 (G. P. II:
(G. P. III:

VIII:

+at 120h), #12

2+ at 96h), and #13 (G. P. IV:

CNBr-SLS-SCM super #21 (G. P. VII:
(G. P. VII:

3+ at

l~Oh);

PGT-

+at 120h);

3+ at 72h) and #27

and Pep. Insol. SCM #24 (G. P.

3+ at 120h) and #30 (G. P. VIII:

4+ at 120h).

The seven anti-SCM sera caused the following reactions,
given in order of increasing severity:
+at 120h), #19 (G. P. VI:

2+ at 120h), #20 (G. P. II:

2+ at 120h), #16 (G. P. IV:
4+ at 120h), #29 (G. P. VIII:
VI:

4+ at 120h).

#23 (G. P. VIII:

3+ at 120h), #26 (G. P. VI:
4+ at 120h), and #25 (G. P.
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Table 17.

Production of hemorrhagic necrosis in guinea
pigs using anti-SCM and anti-GBM antisera.
Antiserum

Animal # Site #
I
1
2
3
4

NRS
HuGBM #1
SLS-GBM #2
Pep-CNBr-SCM #3
SLS-SCM #4

1
2
3
4

NRS
PGT-HuGlom III #5
SLS-CNBr-GBM #6
PGT-HuGlom III #7
HuGlom #8

1
2
3
4

NRS
CNBr-SLS-SCM super #9
SLS-SCM #10
HuGlom #11
SLS-CNBr-GBM #12

II

III

1
2
3
4

NRS
SLS-CNBr-GBM #13
Trypsin res. GBM #14
Pep-CNBr-SCM #15
SCM #16
NRS
SLS-SCM #17
CNBr-SCM super #18
SLS-CNBr-SCM #19
PGT-HuGlom II #20
NRS
SCM #19
SCM #25
SCM #20
SCM #26
NRS
CNBr-SLS-SCM super #21
CNBr-SLS-SCM super #27
SLS-SCM II #22
SLS-SCM II #28

1
2
3
4

NRS
SCM
SCM
Pep
Pep

IV
1
2
3
4

v
1
2
3
4
VI
1
2
3
4
VII

VIII

#23
#29
Insol. SCM #24
Insol. SCM #30

24h 48h 72h 96h 120h
---+

+
+

+
+
3+
3+

+
2+

+
2+

+

+

+
+

2+

+
2+

3+

+
+

+

+

+

2+

+
4+

+
4+

+
3+

2+

3+

3+

3+

+
+
+

3+
2+
3+
4+

2+
2+
3+
4+

2+
4+
3+
4+

3+
2+
3+
3+

4+
+

4+
2+

4+
2+

4+
2+

2+
4+
2+
4+

+

+
2+

3+
3+

2+
3+

+

+

2+

2+

2+
3+
+
4+

+

+
2+
2+
+

+
4+
3+
4+

+
4+
3+
4+

+
4+
3+
4+

+
+

+

2+

+

CHAPTER IV
DISCUSSION
Classical precipitin techniques for the quantitation of specific antibody in sera are (i) wasteful of sera,
(ii) incapable of detecting non-precipitating antibody and
(iii) destructive of the antibody being quantitated.

With

the advent of the use of the immunoadsorbents for the isolation of antibody (28)·, in theory it became possible to
quantitate the concentration of antibody without destroying
it since the antibody is obtained free of iti? antigen and,
there,fore, recoverable for further immunological tests.
Methods used for the creation of immunoadsorbents have
included derivatives of cellulose (6, 12, 28, 41, 42),
polystyrene (39), polyacrylamide (20), and soluble antigen
precipitated by chemical means (18, 30).

The physical

characteristics of Sepharose make it a superior choice in
the construction of immunoadsorbents over previously reported methods.
Sepharose 4B immunoadsorbents were investigated
for their ability to quantitate serum antibody specific
for the antigen bound to the particular immunoadsorbent
column.

If all the antibody in a serum specific for a
84
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particular antigen could be quantitated, the titer of a
serum in a passive hemagglutination test or indirect fluorescent antibody test could be correlated with a concentration of antibody.
4B preparation.

Initial work involved a BSA Sepharose
The data recorded in Table 6 for BSA-

Sepharose 4B experiments were obtained before mechanical
difficulties with the spectrophotometer readings (mentioned
in Results) developed.

Although the column antigen sites

appeared to be saturated in all four runs (as determined
in ring tests), two groups of values (11/21/75-2.64 mg/ml,
12/6/75-2.81 mg/ml, and 12/26/75-1.53 mg/ml, 12/10/75-1.80
mg/ml) which differ significantly from each other were
obtained for specific anti-BSA antibody concentration.
Values obtained for eluted antibody concentrations obtained
from other samples reveal that the same volume of antiserum did not always yield the same amount of antibody in
the eluted fraction (Table 6:

BGG, 6/14/76 or BGG, 4/22/76).

Also, in some cases as the volume of the antiserum passed
over the column increased, the mg of antibody recovered in
the eluted fraction increased (Table 6:

RGG, 1/29/76; RSA,

4/16/76; BGG, 4/29/76; HGG, 5/10/76- in reference to antiHLC serum), decreased (Table 6:

RGG, 1/30/76; HSA, 5/19/76),
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or remained the same (Table 6:

BGG, 6/14/76-successive

samples are listed in the order passed over the immunoadsorbent).

Thus, there appears to be a dynamic relationship

between the volume of antiserum passed over the column and
the amount of antibody bound.

Therefore, the efficiency

of adsorbtion of specific antibody from sera using the
Sepharose immunoadsorbents may be unpredictable.
From passive hemagglutination assay data on titers
of effluent fractions recorded in Tables 9-16, it is apparent that in no single experiment was antibody specific
for the antigen on the immunoadsorbent completely adsorbed
out.

With the exception of the 2.0 ml effluent fraction

of the NRS reconstituted serum affinity sample from 5/19/76
recorded in Table 9 and the 3.0 ml effluent fraction from
6/21/76 rec·orded in Table 10, as the volume of antiserum
passed over the column increased, the titer of the effluent
fraction remained the same or increased.

With the excep-

tion of the 1.0 ml and 1.5 ml samples from 4/29/76 recorded
in Table 13, all titers of serum reconstituted eluted fractions either increased or remained the same as the volume
of the antiserum passed over the column increased.

There-

fore, it cannot be determined from the data whether all
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antigen sites were saturated on an immunoadsorbent during
any particular experiment.
The significance of this finding may lie in a possible role of specific antibody binding physically blocking
binding of antibody to other antigenic determinants.

An

optimum "order" of binding of antibody to the determinants
of a Sepharose bound antigen may exist, such that binding
of an antibody molecule to a particular determinant may
physically block binding of antibody to other determinants
on the same antigen molecule, due to the proximity of the
other determinants to the Sepharose gel.

Therefore, satur-

ation of all possible antibody binding sites may be impossible, and the degree of saturation may vary from experiment to experiment, thus explaining the variable amounts
of antibody isolated when samples of the same serum were
passed over the same immunoadsorbent.
To determine if the absorbance at 280 nm of the
eluted fractions was due solely to rabbit gamma globulin
and not other serum proteins, immunoelectrophoresis of
material from the pooled eluted fractions of the four antiBSA experiments reported in Table 6 was run.

As evidenced

by the precipitation of anti-RGG and anti-WRS with the
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eluted fraction of rabbit anti-BSA and RGG antigen (see
Fig. 4), the eluted fraction contains gamma globulin free
of other serum proteins.

Therefore, the absorbance at

280 nm of eluted fractions may be used to determine· the
concentration of.eluted antibody.
Initial proof of the specificity of eluted antibody was the precipitation of eluted antibody in ring tests

.

with a solution of the homologous antigen.

Figs. 3A, 3B,

and Table 7 give the results of a dual test.for both the
specific and cross reactivity of eluted antibody.

An in-

dication of the activity of eluted antibody is the similarity in the size of the area under the curves of respective effluent and eluted fractions from successive runs of
the antibody solution on the same irnmunoadsorbent.

Ring

tests of the effluent fractions displayed in Fig. 3A vs. a
BSA antigen solution gave no precipitation.

It cannot be

determined whether this result is due to non-specific or
inactive antibody.

The ability of the HSA-Sepharose 4B

preparation to show cross reactivity of BSA antibody with
HSA antigen is indicated by the eluted fractions displayed
in Fig. 3B from a run of anti-BSA antibody over the HSA
column; antibody from the eluted fractions precipitated
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with both HSA and BSA in ring tests.
The ability of Sepharose immunoadsorbents to isolate cross reactive antibody should serve as a warning for
investigators using the irnmunoadsorbents to isolate specific antibody.

If the isolated antibody is to be used in

experiments requiring specificity for homologous antigen
alone, the eluted antibody fraction should first be adsorbed with the appropriate cross reacting antigens.
The discrepancy between total area under curves
in Fig. 3A (2143 square units) and Fig. 3B (2770 square
units) is best explained by the method used to calculate
the curves.

As shown in Figs. 3A and 3B, the curves re-

presenting the absorption of the eluted fractions failed
to return to baseline.

Therefore, arbitrary base lines had

to be drawn to facilitate calculation of the areas under
the respective eluted fraction curves.

Although the inves-

tigator believes that lines were drawn consistently for the
two eluted fractions in each figure, a discrepancy may have
arisen in the comparison of the total areas under curves
between figures.
Results of other experiments supporting the ability of Sepharose immunoadsorbents to isolate cross reactive
antibody are reported in Tables 14 and 15.

Recoveries of
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hemagglutinating activity of NRS reconstituted serum affinity samples from passage of two consecutive 1.0 ml samples
of a goat anti-RGG serum over a BGG-Sepharose immunoadsorbent were 3/3 and 2/3 on RGG coated RBC (Table 14) and
2.5/3.5 and 3.25/3.5 on BGG coated RBC (Table 15).

A com-

parison of the cross reactivity of serum affinity samples
from passage of a 1. 0 ml sample of anti-BGG serum over the
RGG-Sepharose immunoadsorbent was limited by the low titers
of the BGG standard serum on RGG coated RBC as reported in
Table 14 (non-reconstituted fractions:
stituted fractions:

1,280; NRS recon-

160).

The increased fluorescence observed in indirect
fluorescent antibody test on carbohydrase treated kidney
sections vs. untreated human kidney sections with anti-GBM
and anti-SCM .sera has been documented (3, 4).

In the

future, the effect on antigenicity of GBM and SCM preparations treated to remove carbohydrate moieties will hopefully be observed by binding such antigens to Sepharose
and observing differences in antibody binding as compared
to Sepharose preparations of homologous antigens not
treated with the specific enzyme involved.
Data recorded in Table 8 indicate that Sepharose
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immunoadsorbents will be useful tools in such studies.

The

results indicate that although proteose bound to Sepharose
less efficiently (Table 5:

#1, 0.01 umol/ml; #2, o•. 04 umol/

ml) than sialidase treated proteose (Table 5:

#1, 0.03 umol/

ml; #2 0.05 umol/ml), the combining ratios indicate that
sialidase treated proteose bound less antibody (Table 8:
#1, .024, .011; #2 .011, .013) in each case as compared
to the untreated proteose preparation (Table 8:

#1, .081,

.076; #2, .017, .021, .017), suggesting that removal of
sialic acids destroyed major antigenic determinants which
the· antiserum was specific for.
A seemingly paradoxical result occurred when determining titers with proteose and sialidase treated proteose
RBC; RBC coated with sialidase treated proteose consistently
gave higher titers with eluted fractions from runs on both
proteose and sialidase treated proteose Sepharose columns
(data not shown).

Therefore, a better explanation for the

basis of the combining ratios may be that removal of sialic
acids allowed the proteose to bind to Sepharose in a manner
that sequestered major antigenic determinants from the antiserum.

Thus, it could not be assumed that a precipitous

drop in the adsorption of specific antibody from a serum
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using an enzyme modified antigen immunoadsorbent, as compared to a native antigen immunoadsorbent, was due to removal of a particular moiety of the antigen:

The effect,

if any on binding of the antigen to Sepharose after enzyme
digestion of the antigen should always be determined.
Although the hemagglutinating activity of the effluent fractions were drastically lower than titers of
original sera, with few exceptions (Table 13:
and 1/31/76), the log
did not equal the log

2
2

1/30/76

of the serum affinity sample titer
of the respective standard serum

titer.
An assumption was made that perhaps the antibody
in the eluted fractions was being non-specifically adsorbed
by the polyvinyl Microtiter plates, due to too low a protein concentration in the eluted fractions.

This phenomenom

has been reported and the high affinity of IgG for fresh
plastic is in fact taken advantage of in radioimmunoassay
procedures (17).
Therefore, to raise the protein concentration of
the eluted fraction, an aliquot of the fraction was diluted
1: 2 in NRS.

Initially, the tite·rs of several HSA samples

were redetermined.

By observing Table 9, with careful
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consideration for titers of standard serums in each case,
it can be seen that some NRS reconstituted eluted fractions
did in fact show a respectable gain in titer with the corresponding loss of hemagglutination activity by the respective effluent fractions.

Titers were redetermined for the

other completed samples using the 1:2 NRS reconstitution
technique; all titers of samples obtained afterward were
determined using only NRS reconstituted eluted fractions.
However, regardless of whether the eluted fractions
were reconstituted with normal serum, the fact remains that
in the majority of cases the hemagglutinating activity of
the original antiserum {standard serum) is not totally
recovered in the serum affinity sample.

Whether this is

a result of irreversible protein denaturation caused by
the elution through reconstitution steps of handling the
fractions {elution by acidic buffer, neutralization of the
fraction with base, dialysis, lyophilization, and reconstitution with BBS) and/or by storage of the eluted antibody
in buffer is not known.
Numerous reports in the literature involving use
of Sepharose immunoadsorbents fail to mention data on the
activity of the isolated antibody.

Frequently, it cannot
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be determined if a specific manipulation on the isolated
antibody fraction (e.g. concentration) was required before
the results involving the isolated antibody were obtained.
Therefore, mention of the activity in_an immunologic test
of antibody isolated using irnmunoadsorbents should always
be given.
A partial explanation for the cause of the apparent denaturation of eluted antibody may be found in a
report by Jaquet et al. (20).

Using a DNP-BSA-polyacryl-

amide gel imrnunoadsorbent, anti-dinitrophenyl antibodies
were isolated from MOPC-315 (an IgA myeloma) ascites fluid.
A 0.1 M glycine-HCL buffer, pH 2.3, was used to elute the
specific antibody from the irnmunoadsorbent.

Titers of

unadsorbed ascites fluid (3,340,800 were compared to
titers of a 10.0 ml adsorbed (208,800) fraction and respective eluted fractions (50,200 and 6,400-the investigators split the eluted fraction on the basis of ascending
and descending fractions of the elution Gurves) in passive
hemagglutination assays on DNP-coated RBC.

In the termin-

ology of this thesis, the titer of the standard serum
(unadsorbed ascites fluid) had a log

2

of approximately 11.5,

while the titer of the serum affinity sample (adsorbed
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ascites fluid plus eluted fractions) had a log
imately 14.5.

2

of approx-

Results for a 5.0 ml sample were 11.5 for

the "standard serum" and 12.25 for the "serum affinity
sample".
Prior to the assays, the concentration of each of
the two eluted fractions apparently had been adjusted to
6.0 mg protein/ml.

The pH of the fractions from the ascen-

ding portion of the elution curve were "basic".

The pH

of the fractions from the descending portion of the elution
curve were acidic, and were adjusted to pH 7.5 by the addition of 0.5 M Tris buffer, pH 8.0.

Since the fractions

were concentrated by negative pressure and dialyzed against
PBS before use, the loss of activity in the fractions obtained from the descending portion of the elution curve
were probably a direct result of the acidic conditions in
which they were initially collected.
During.the coupling stage in the preparation of
the RGG and BGG columns, essentially all of the ligand
added bound to the Sepharose (Table 5).

With the excep-

tion of HGG, no other antigen used in the course of ·the
experiments displayed such a high binding efficiency.
However 11 the high titers of the effluent fractions recorded
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in Table 13 suggest that the RGG-Sepharose preparation was
a very poor inununoadsorbent.

Hemagglutination data recorded

in Table 12 for BGG showed some of the lowest recovery of
hemagglutinating activity in eluted fractions as compared
to the other antigen-Sepharose systems.
The assumption was made that the binding of RGG
and BGG to Sepharose was fundamentally different in some
unknown fashion as compared to the other antigens used,
and that as an antiserum was passed over the RGG-Sepharose
'

or BGG-Sepharose columns a great deal of non-specific

ad~

sorption of serum proteins was occurring with possibly a
concomitant loss of the original antigen from the column.
As a result, with respect to antigen specificity the exact
nature of the antibody obtained in the elution step in
experiments with RGG-Sepharose and BGG-Sepharose columns
appeared questionable.
Hofstee (10) has reported a high degree of essentially irreversible non-specific binding of proteins to
ligand Sepharose preparations.

In an attempt to determine

if non-specific binding of serum proteins was occurring and,
therefore, affecting the binding and elution of specific
antibody, amino acid analyses were determined on RGG-
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Sepharose, BGG-Sepharose, and trypsin solubilized GBM
)10,000 dalt.-Sepharose before and after use in affinity
chromatography experiments.

In Table 4, results are re-

ported in umol/100 umol since a significant increase in
the percent composition of a group of amino acids over
other amino acid constituents would indicate binding of
serum proteins other than imrnunoglobulin to the column.
With the exception of arginine, histidine, glutamic
acid, valine, methionine, and alanine, there is probably
no significant difference between the amino acid content
of the unused and used GBM preparations.

A good indication

of the stability of the gel is given by the mg protein/ml
gel figures for the unused (0.26) and used (0.30) gels.
Significant differences in the amino acid content of the
unused and used gels of RGG are apparent with respect to
lysine, aspartic acid, alanine, valine, leucine, tyrosine,
phenylalanine, threonine, proline and methionine.

Dif-

ferences in amino acid content of the BGG preparations were
present with respect to histidine, arginine, serine, aspartic acid, proline, valine, half-cystine, isoleucine, leucine,
tyrosine, methionine, and glycine.

The vast difference in

mg protein/ml gel between the unused (RGG:

0.70, BGG:

1.44)
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and used (RGG:

1.61, BGG:

3.02) preparations would seem

to indicate a great deal of protein binding after passage
of sera over the columns that was stable to elution with
the glycine buffer.
When trying to formulate an explanation for the

•
binding
of proteins which were stable to elution with glycine-HCL buffer, one is faced.with the difficult task of
attributing the binding to properties of either the antigen
itself or as a result of interaction of the bound antigen
with Sepharose.

The amino acid composition of the GBM-

Sepharose, the only non-irnrnunoglobulin Sepharose preparation analyzed, indicates that the same theories would not
be applicable to the GBM-Sepharose preparation.

Heinzel

et al. (16) reported that urethan groups, which arise from
the imidocarbonate groups produced by activation of Sepharose with CNBr, were capable of binding other serum proteins
which were then eluted off along with specific antibody.
Possibly, elution of non-specific proteins from urethan
groups may be prevented on the irnrnunoglobulin Sepharose
irnrnunoadsorbents.

This fact, coupled with possible dena-

turation of the irnrnunoglobulin ligand attached to Sepharose
due to repeated passage of an acidic buffer during elution,
may explain the decrease in efficiency of the RGG and BGG
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columns with use, as observed by this investigator, after
comparing graphs of elution peaks from early and late runs
of the same volumes of sera (data not shown).

Another pos-

sible explanation for the decrease in efficiency may be
that column antigen was eluted off along with the eluted
antibody.

The increased protein concentration of the used,

compared with unused, preparations argues against this theory.
Secondly, the stability of Sepharose bound antigen is supported by results of immunoelectrophoresis of the eluted
fraction from chromatography of a goat anti-RGG serum over
a RGG-Sepharose column, shown in Fig. 4, which revealed
that anti-RGG formed a precipitin arc with RGG (the .identical preparation used as ligand for the RGG Sepharose
column) but not with the eluted fraction of the goat antiserum.

Therefore, loss of column bound antigen in the

eluted fraction was not detectable.
Another consideration arising from Table 4 is the
disparity between the mg ligand bound/ml gel as calculated
by the dry weight of ligand recovered (reported in Table 5)
and the mg protein/ml gel as determined by amino acid analysis.

In all probability this observation was due to the

hydrolysis of the protein while attached to Sepharose, since
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hydrolysis of protein in the presence of carbohydrate may
result in very large losses of amino acids (15).
The amino acid analysis recorded in Table 3 for
trypsin solubilized SCM )10,000 dalt. was in fairly close
agreement with an analysis reported by Lange (25) for a
PGT-SCM fraction.

The trypsin solubilized GBM )10,000 dalt.

bears little resemblance to a PGT-GBM fraction isolated
previously (25).

The amino acid analyses of the fractions

resultant from trypsin digestion of GBM did indicate that
the four different fractions were of significantly different amino acid composition, but have some basic similarities between amino acids in highest (glycine, hydroxyproline) concentration.
Data recorded in Table 16 for hemagglutination of
GBM coated RBC by an anti-PGT HuGlom II serum [a serum
chosen because of the strong necrotic reaction it produced
on guinea pigs recorded in Table 17, and also the strong
fluorescence obtained from it in indirect fluorescent antibody tests (3)] and the effluent and eluted fractions of
the serum recovered after chromatography on the GBM-Sepharose column, indicate that trypsin solubilized GBM )3,500
<8,000 dalt. shares antigen(s) in common with trypsin solu-
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bilized GBM>10,ooo dalt.

The GBM (3,500)8,000 dalt. may

in fact be a subunit of the larger structure, indicated by
the fact that the smaller m. w. fraction contains significantly higher percentages of lysine and arginine than the
)10,000 dalt. fraction.

Therefore, cells coated with tryp-

sin solubilized GBM )3,500(8,000 may be coated with a preparation which is greatly enriched in the significant antigen
as compared to the cells coated with the trypsin solubilized
GBM )10,000 dalt.

However, it may be questionable to ex-

plain the observed difference in titers on the basis of a
concentration effect of antigen alone on the cells.

Mini-

mal concentrations of antigens on the RBC are necessary to
give positive hemagglutination reactions, indicated by the
fact that supernatants from a first coupling of cells may
be used to couple a second batch of cells, and

th~t

too

much antigen causes autoagglutination of the RBC (8, 37).
Also, Sheoiri (35) reported that over a fairly wide range
of antigen concentration (4,700 HGG molecules/REC to 58,500
HGG/RBC), a constant antibody concentration (SO molecules/
RBC) displayed approximately the same titer •
.An important point to be derived from Table 16 is
that a method has been devised to concentrate effectively
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an immunological reagent and thereby increase its sensitivity for the detection of antigen.

Usefulness of the method

was borne out with the knowledge that the concentrated
eluted fraction of anti-PGT HuGlom II gave more intense
fluorescent staining than the original serum.

Another

point derived from the fluorescent antibody tests is that
the results prove that the antibody isolated by affinity
chromatography and reactive for a solubilized GBM prepara-

--

tion was reactive also for the antigen in situ.
Rapaport et al. (33) reported the production of
hemorrhagic necrosis in guinea pigs by intradermal injection of anti-group A, type 12 SCM sera followed by challenge
with 100 ug epinephrine intradermally into the same site
15 min later.

The hemorrhagic necrosis elicited was simi-

lar to that described by Thomas (40) in rabbits using an
intradermal injection of endotoxin followed by challenge
with epinephrine.

Although necessary for the necrotic

reaction, the method by which epinephrine exerts its potentiating effect is unknown.

Thomas theorized that endotoxin

exerted an effect on blood vessels which altered their reactivity to epinephrine to an extent that the hormone became
a potent necrotizing agent (40).
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The reaction produced using anti-SCM sera is believed
to be due to a cross reaction between the injected anti-SCM
antibodies and host tissue.

Utilizing antisera prepared

against group A, type 12 SCM and solubilized fractions of
type i2 SCM, Lange obtained data consistent with a group
distribution of the cross reacting antigens in the outbred
strain of Hartley guinea pigs used (27).
Recorded in Table 17 is the first report of the
cross reaction between GBM antigens and guinea pig tissue
antigens, as indicated by the strong hemorrhagic necrosis
produced by anti-HuGlom #8, anti-SLS-CNBr-GBM #i2, antitrypsin-res. GBM #14, and anti-PGT-HuGlom II.

As indicated

in Results and recorded in Table 17, a large number of the
antisera prepared against the same SCM preparation produced
varying degrees of necrosis.

This result is probably due

to the antibody response of the individual rabbit inununized
with the particular SCM preparation, if the assumption by
Lange (27) of the group distribution of the cross reactive
antigens is correct.
In the future, GBM and SCM Sepharose inununoadsorbents may provide a method for determining the basis of
the variability in severity of necrosis caused by antisera
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prepared against various GBM and SCM antigens.

Antigens

identical to. those used to irmnunize rabbits from which the
sera were obtained would be coupled to Sepharose.

Specific

antisera would be run over homologous immunoadsorbents,
and the specific antibody isolated.

An equal amount of

each specific antibody population would be dissolved separately in an equal volume of NRS (previously shown to
cause no hemorrhagic necrosis), and the hemorrhagic necrosis
produced by each preparation on the same and different
guinea pigs compared.

Using this method it may be deter-

mined (i) whether the severity of hemorrhagic necrosis produced by an antiserum was due to the response of an individual rabbit, or antigenic characteristics of the particular
guinea pig tissue; and (ii) whether a particular antigen
preparation contained the antigens irmnunologically related
to guinea pig tissue.

As an explanation, if the titer of

a particular antiserum vs. the antigen was lower than the
titer of another antiserum prepared against the same antigen,
a simple concentration step (similar to the concentration
of the anti-PGT-HuGlom II eluted fraction-see Table 16) on
the eluted fraction of the former would bring its activity
up to the activity of the latter.

However, one rabbit may
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have responded selectively to certain determinants in the
antigenic preparation.

Another rabbit challenged with the

same antigen could respond selectively to another group
of determinants.

In this case, the antiserum containing

antibody in high titer against the GBM or SCM antigens
immunologically related to guinea pig tissue would cause
the strongest reaction, regardless of whether the concentrations in the two antisera of antibody specific for the
original antigen were equal.

If an antiserum against a

particular antigen did not produce necrosis, a specific
antibody could be obtained using the appropriate imrnunoadsorbent.

After concentrating the eluted fraction, if

hemorrhagic necrosis was still not produced, then it could
be stated with greater certainty that the antibody specific
for the GBM or SCM preparation was not cross reactive with
guinea pig tissue antigens.
A problem with the above hypothesis is the lack of
knowledge concerning the loss of activity of specific antibody isolated utilizing Sepharose imrnunoadsorbents.

Since

some loss of antibody activity is unavoidable, a system
must be devised in which the loss of antibody activity can
be predicted with consistency.

CHAPTER V
SUMMARY
Sepharose 4B immunoadsorbents were constructed
using as antigens RGG, BGG, HGG, BSA, HSA, protease, sialidase treated protease, trypsin solubilized GBM )10,000
dalt., and trypsin solubilized SCM)l0,000 dalt.

The

inununoadsorbents were used for the investigation of their
ability to isolate, free of other serum proteins, specific
and cross reactive antibody for the antigen coupled to the
inununoadsorbent.

An attempt was made to devise a method,

using the Sepharose inununoadsorbents, for determining the
concentrations in sera of specific antibody.

The effect

of enzymatic digestion of antigen on the binding of the
antigen to Sepharose and subsequent adsorption from sera
of specific antibody on the inununoadsorbent were investigated using proteose and sialidase treated proteose.
Stability of immunoadsorbents was investigated using amino
acid analysis of inununoadsorbents before and after passage
of sera.
Recovery of antibody activity was determined using
passive hemagglutination assays.
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Titers were determined
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on effluent and eluted fractions obtained from passage of
a serum sample over an immunoadsorbent.

Titers were re-

ported as the reciprocal of the dilution and the log
the dilution.

The sum of log

2

2

of

of titers of respective

effluent and eluted fractions (each matched effluent and
eluted fraction being termed a "serum affinity sample")
were compared to the log

2

of the titer of the original

serum (termed "standard serum") to obtain an idea of the
recovery of antibody activity in the serum affinity samples.
Eluted antibody fractions were reconstituted (1/1) in
normal serum in an attempt to optimize recovery of hemagglutinating activity.
The use of Sepharose immunoadsorbents for quantitating the entire antibody content of a serum specific for
a particular antigen had a limited applicability.

Using

immunoelectrophoresis, the antibody eluted from the columns
was established to be specific and free of other serum
proteins, but may have shown a high loss of activity as
determined in hemagglutination assays.

For most immuno-

logic testing it was necessary to reconstitute the eluted
fraction in a serum fraction in order to regain optimal
activity.

The Sepharose immunoadsorbents have been shown

lOS
to be capable of isolating cross reactive antibody.

Enzy-

matic digestion of antigen may have significantly altered
the binding of the antigen to Sepharose

~nd

thereby blocked

possible antigenic determinants, thus decreasing the efficiency of the immunoadsorbent to adsorb specific antibody from

ser~.

The stability of Sepharose immunoadsor-

bents and/or apparently irreversible binding of serum
proteins on Sepharose immunoadsorbents may depend on the
particular antigen used for the immunoadsorbent.

A new

potent GBM antigen may have been isolated, but further
proof will be necessary since decisions based on hemagglutination titers alone may be fallacious.

A quick and

easy method has been devised to concentrate specific
antibody and thereby improve the detectability of its
interaction with antigen.

Finally, the production of

hemorrhagic necrosis in guinea pigs using anti-GBM antisera has been reported.
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